{"title": "Guadalupe Garcia-Tsao", "author": "Guadalupe Garcia-Tsao", "url": "https://www.yalemedicine.org/specialists/guadalupe-garcia-tsao", "hostname": "yalemedicine.org", "description": "Guadalupe Garcia-Tsao, MD, is chief of digestive diseases for the VA-CT Healthcare System and director of the Clinical and Translational Core of the Yale Liver Center. She treats patients with liver disease, and has particular expertise in cirrhosis and portal hypertension. She also manages patients with portal hypertension caused by conditions other than cirrhosis. Dr. Garcia-Tsao has completed many clinical studies that have led to improving the management of patients with complications of cirrhosis and is currently interested in issues regarding the progression (or regression) of cirrhosis. \"Patients with cirrhosis and portal hypertension have inspired my clinical practice and my research,\" says Dr. Garcia-Tsao, a professor of medicine (digestive diseases) at Yale School of Medicine. \"Cirrhosis is the end-stage of any chronic liver disease, and with advances in science, we have different measures to better treat the complications of cirrhosis. We are currently working at measures to prevent these complications from even occurring or to induce cirrhosis regression.\"", "sitename": "Yale Medicine", "date": "2023-01-01", "cleaned_text": "- Yale Digestive DiseasesTemple Medical Center40 Temple Street, Ste 1ANew Haven, CT 06510 - VA Connecticut Healthcare SystemVA Connecticut Healthcare950 Campbell Avenue, Wing West Haven CampusWest Haven, 06516 Guadalupe Garcia-Tsao, MD, FRCP [Learn more telehealth](/patient-tools/telehealth) Biography Guadalupe Garcia-Tsao, MD, is chief of digestive diseases for the VA-CT Healthcare System and director of the Clinical and Translational Core of the Yale Liver Center. She treats patients with liver disease, and has particular expertise in cirrhosis and portal hypertension. She also manages patients with portal hypertension caused by conditions other than cirrhosis. Dr. Garcia-Tsao has completed many clinical studies that have led to improving the management of patients with complications of cirrhosis and is currently interested in issues regarding the progression (or regression) of cirrhosis. \"Patients with cirrhosis and portal hypertension have inspired my clinical practice and my research,\" says Dr. Garcia-Tsao, a professor of medicine (digestive diseases) at Yale School of Medicine. \"Cirrhosis is the end-stage of any chronic liver disease, and with advances in science, we have different measures to better treat the complications of cirrhosis. We are currently working at measures to prevent these complications from even occurring or to induce cirrhosis regression.\" Titles - Professor of Medicine (Digestive Diseases) Education & Training - Liver Research fellowshipYale University (1985) - GI FellowshipInstituto Nacional de la Nutricion (1982) - Intern/ResidentInstituto Nacional de la Nutricion (1980) - MDUniversidad Nacional Autonoma de Mexico (1977) Languages Spoken - English - Italiano (Italian) - Espa\u00f1ol (Spanish) Additional Information - Jimenez J, Garcia-Tsao G, Saffo S. Emerging concepts in the care of patients with cirrhosis and septic shock World Journal M, Garcia-Tsao G. Update in the Treatment of the Complications of Cirrhosis Clinical for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36972386)Rabiee A, Mahmud N, Falker C, Garcia-Tsao G, Taddei T, Kaplan D. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis](https://doi.org/10.1016/j.jhepr.2023.100727)D\u00edaz L, Fuentes-L\u00f3pez E, Ayares G, Idalsoaga F, Arnold Valverde M, Perez D, G\u00f3mez J, Escarate R, Villal\u00f3n A, Ram\u00edrez C, Hernandez-Tejero M, Zhang W, Qian S, Simonetto D, Ahn J, Buryska S, Dunn W, Mehta H, Agrawal R, Cabezas J, Garc\u00eda-Carrera I, Cuy\u00e0s B, Poca C, Louvet A, Garc\u00eda-Tsao G, Roblero J, Abraldes V, Kamath P, Arrese M, Singal A, Bataller R, Arab J. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis JHEP Reports 2023, 100727. [DOI: 10.1016/j.jhepr.2023.100727](https://doi.org/10.1016/j.jhepr.2023.100727). [O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY](https://doi.org/10.1016/j.aohep.2023.101035)Idalsoaga F, D\u00edaz L, Ayares G, Arnold J, Dunn W, Li Y, Singal A, Simonetto D, Ayala-Valverde M, Perez D, Gomez J, Escarate R, Fuentes-L\u00f3pez E, Ramirez C, Morales-Arraez D, Zhang W, Qian S, Ahn J, Buryska S, Mehta H, Waleed M, Stefanescu H, Horhat A, Bumbu A, Attar B, Poca M, Pastor G, Sarin S, Maiwall R, Jalal P, La Tijera M, Kulkarni A, P N, Salazar P, Skladan\u00fd V, Clemente-Sanchez P, Mendizabal S, Dirchwolf M, Vargas V, Jimenez C, Garc\u00eda-Tsao G, Ortiz G, Abraldes J, Kamath P, Arrese M, Shah V, Bataller R, Arab J. O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY 101035. [DOI: 10.1016/j.aohep.2023.101035](https://doi.org/10.1016/j.aohep.2023.101035). - Nadim M, Garcia-Tsao G. Acute Kidney Injury in Patients with Cirrhosis New England Journal Of Medicine 2023, hypertension assessments in nonalcoholic steatohepatitis cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36647687)Noureddin M, Goodman Z, Tai D, Chng E, Ren Y, Boudes P, Shlevin H, GarciaTsao G, Harrison S, Chalasani N. Machine learning liver histology scores correlate with portal assessments Cirrhosis Complicated by Portal Hypertension](http://www.ncbi.nlm.nih.gov/pubmed/36516940)Ferral H, Schepis F, Gaba Z, Garcia-Pagan J. Endovascular Assessment of Liver Hemodynamics in Patients with Cirrhosis Complicated by Portal Hypertension Journal Signature in Patients with Alcohol-Associated Cirrhosis](https://doi.org/10.1182/blood-2022-162633)Allen C, Butt A, Zhao X, Li F, Bahel P, Chang C, Chun H, Gu S, Hwa J, Jakab S, Chen B, Garcia-Tsao G, Rinder H, To U, McConnell M, Lee A, Pine A. Plasma Proteomic Profiling Illustrates Endothelial and Complement Signature in Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36328307)Bajaj J, Lai J, Tandon P, O'Leary J, Wong F, Garcia-Tsao G, Vargas H, Kamath P, Biggins S, Limon-Miro A, Shaw J, Mbachi C, Chew M, Golob Deeb J, Thacker L, Reddy K. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH\": Comment parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH\": Comment from Hartmann et 10.1007/978-3-031-08552-9_47](https://doi.org/10.1007/978-3-031-08552-9_47). - T, C, D'Amico G, La Mura V, Piano S, Tandon P, Turco L. Preventing Further Decompensation: Consensus 7 2022, 579-583. [DOI: 10.1007/978-3-031-08552-9_51](https://doi.org/10.1007/978-3-031-08552-9_51). [Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a labbased model](http://www.ncbi.nlm.nih.gov/pubmed/36214066)Rabiee A, Deng Y, Ciarleglio M, Chan JL, Pons M, Genesca J, GarciaTsao G. Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of A Meta-analysis Based on Randomized J, Pivalizza E, Garcia-Tsao G. Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized at hospital admission with nosocomial development in patients cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36017804)Bajaj P, GarciaTsao G, Kamath Wong F, Lai J, Vargas H, Thuluvath PJ, Subramanian RM, PenaRodriguez M, of metabolites and gut microbiota at hospital admission with nosocomial infection development in patients histologic scores correlating with portal pressures and the development of varices in NASH patients with cirrhosis](https://doi.org/10.1016/s0168-8278(22)01564-1)Noureddin M, Tai D, Chng E, Ren Y, Boudes P, Shlevin H, Harrison S, Garcia-Tsao G, Goodman Z, Chalasani N. FRI516 Derivation of machine learning histologic scores correlating with portal pressures and the development of varices in NASH patients with automated detection of septa and nodules in needle liver biopsies of NASH cirrhosis](https://doi.org/10.1016/s0168-8278(22)01557-4)Noureddin M, Tai D, Chng E, Ren Y, Boudes P, Shlevin H, Harrison S, Garcia-Tsao G, Chalasani N, Goodman Z. FRI509 Use of second-harmonic generation microscopy for automated detection of septa and nodules in needle liver biopsies of at admission have comparable outcomes in a multi-center cohort of inpatients with cirrhosis](https://doi.org/10.1016/s0168-8278(22)02066-9)O'Leary J, Reddy K, Tandon P, Kamath P, Garcia-Tsao G, Wong F, Lai J, Subramanian R, Thuluvath P, Maliakkal B, Vargas H, L, Bajaj J. SAT496 SBP vs. non-SBP bacterial infections at admission have comparable outcomes in a multi-center cohort of inpatients of nosocomial infections in inpatients with cirrhosis](https://doi.org/10.1016/s0168-8278(22)01041-8)Bajaj J, O'Leary Garcia-Tsao P, Subramanian R, Vargas H, McGeorge S, Fagan A, Wong F, Lai J, Thacker L, Reddy R. THU494 Serum metabolites on admission associate with the development of nosocomial infections in inpatients Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites](https://doi.org/10.1155/2022/5065478)Bajaj J, Fischer J, Yeramian P, Gavis Fagan A, Angeli P, Garcia-Tsao G, Adams J, Markham P. Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous nonselective betablockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites](http://www.ncbi.nlm.nih.gov/pubmed/35899241)Turco L, Garc\u00edaTsao G. Portal pressure reductions induced by nonselective betablockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites decompensated cirrhosis: an autopsy study](http://www.ncbi.nlm.nih.gov/pubmed/36160304)Saffo S, Jain D, Sanchez H, Garcia-Tsao G. Invasive fungal infections are underdiagnosed in hospitalized patients with decompensated cirrhosis: OCCURRENCE OF NOSOCOMIAL INFECTIONS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(22)62677-5)Bajaj J, O'Leary J, Tandon P, Garcia-Tsao G, Kamath P, Thuluvath P, Subramanian R, Lai J, Vargas H, Mcgeorge S, Fagan A, Wong F, Thacker L, Reddy K. 82: SERUM METABOLITES ON ADMISSION ASSOCIATE WITH OCCURRENCE OF NOSOCOMIAL AT ADMISSION HAVE COMPARABLE OUTCOMES IN A MULTI-CENTER COHORT OF INPATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(22)63501-7)O'Leary J, Reddy K, Tandon P, Kamath P, Garcia-Tsao G, Wong F, Lai J, Subramanian R, Thuluvath P, Maliakkal B, Vargas H, L, Bajaj J. Sa1456: SBP VERSUS NON-SBP BACTERIAL INFECTIONS AT ADMISSION HAVE COMPARABLE OUTCOMES IN A MULTI-CENTER COHORT to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated A Global Study](http://www.ncbi.nlm.nih.gov/pubmed/35501978)Morales-Arr\u00e1ez Altamirano J, Cruz-Lemini M, Thursz M, Atkinson S, Sarin S, Kim W, Chavez-Araujo R, la Tijera M, Singal A, Shah V, Kamath P, Duarte-Rojo A, Charles E, Vargas V, Jager M, Rautou P, Rincon D, Zamarripa F, Restrepo-Guti\u00e9rrez P, Louvet A, Garc\u00eda-Tsao G, Gonz\u00e1lez J, Verna R, Argemi J, Fern\u00e1ndez-Carrillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study OF 3-MONTH HOSPITALIZATION IN A MULTI-CENTER CIRRHOSIS COHORT](https://doi.org/10.1016/s0016-5085(22)60136-7)Bajaj J, Lai J, Tandon P, O'Leary J, Garcia-Tsao G, Wong F, Vargas H, Kamath P, Biggins S, Shaw J, Limon-Miro A, Chew M, Mbachi C, Thacker L, Reddy R. 256: PRIOR PERIODONITIS AND PATIENT-REPORTED OUTCOMES PREDICT THE RISK OF Kamath PS, Tandon JS. Prognosis of hospitalized patients with cirrhosis and acute Liver Hag M, Abraldes JG, Alvarado E, Clemente Ravi S, Alves A, Alboraie M, Altamirano R, Caballeria J, Cabezas J, Carvalhana S, Cortez-Pinto H, Costa MR, Masson S, Mathurin P, Mendez-Sanchez N, Miquel R, Moreno C, Mounajjed T, Odena G, Kim W, Sancho-Bru P, Sands R, Szafranska J, Verset L, Schnabl B, Sempoux C, Shah RE, Straub BK, Verna E, Tiniakos JT, M, Mueller S, St\u00e4rkel P, Bataller R. Clinical, histological and molecular profiling of different stages of alcohol-related Gut Ripoll J, Ba\u00f1ares M, Benajiba L, Berzigotti A, Bureau C, Calvaruso V, Cardenas A, D'Amico G, De Gottardi A, Dell'Era A, Escorsell A, Fallowfield J, Rodrigues S, Gracia-Sancho J, Han G, Hernandez-Gea V, Jia J, Kiladjian J, Krag A, Laleman W, La Mura V, Lens S, Luo X, Mandorfer M, Murad S, Paradis V, Patch D, Piano S, Pinzani M, Plessier A, Primignani M, Procopet D, Villanueva C, Wanless I, Yoshiji H. Baveno VII - Renewing consensus in the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated A Global Study](http://www.ncbi.nlm.nih.gov/pubmed/34962498)Morales-Arr\u00e1ez Altamirano J, Cruz-Lemini M, Thursz M, Atkinson S, Sarin S, Kim W, Chavez-Araujo R, la Tijera M, Singal A, Shah V, Kamath P, Duarte-Rojo A, Charles E, Vargas V, Jager M, Rautou P, Rincon D, Zamarripa F, Restrepo-Guti\u00e9rrez P, Louvet A, Garc\u00eda-Tsao G, Gonz\u00e1lez J, Verna R, Argemi J, Fern\u00e1ndez-Carillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant Clinical AND AFTER HCV CURE AND CORRELATION WITH CLINICAL OUTCOMES](https://doi.org/10.1016/j.aohep.2021.100493)Ragazzo T, Garcia-Tsao G, Mazo D, Ziteli P, Oliveira C, Singer J, F, Pessoa M. O-6 NON-INVASIVE ASSESSMENT OS HEPATIC FIBROSIS BEFORE AND AFTER HCV CURE AND CORRELATION WITH Annals Of Hepatology 2021, 24: 100493. [DOI: Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases](http://www.ncbi.nlm.nih.gov/pubmed/33942342)Biggins SW, Angeli P, GarciaTsao G, Gin\u00e8s P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, Evaluation, and of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With AlcoholAssociated Hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/34109723)Musto JA, Eickhoff J, VenturaCots M, Abraldes JG, BosquesPadilla Verna EC, Brown RS, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross D, Louvet G, Schnabl B, Bataller R, Lucey MR. The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With AlcoholAssociated Hepatitis Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/34002868)Bajaj JS, GarciaTsao G, Reddy KR, O'Leary P, Subramanian RM, Thuluvath P, Fagan A, T, LR, Wong F. Admission Urinary and Serum Metabolites Predict A, Parmer C, Yang H, Jain D, Lim B, Goodman AL, GarciaTsao G. Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With G, P. Determinants of increased thrombotic tendency in Liver Injury Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death](http://www.ncbi.nlm.nih.gov/pubmed/34004326)Chew M, Tang Z, Radcliffe C, Caruana D, Doilicho N, Ciarleglio MM, Deng Y, Garcia-Tsao G. Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death ON ADMISSION PREDICT THE DEVELOPMENT OF AKI AND NEED FOR DIALYSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(21)02565-8)Bajaj J, Garcia-Tsao G, Reddy R, O'Leary J, Vargas H, Lai J, Kamath P, Tandon P, Subramanian R, Thuluvath P, Fagan A, Sehrawat T, De La R, Wong F. 431 SPECIFIC URINARY AND SERUM METABOLITES ON ADMISSION PREDICT THE DEVELOPMENT OF AKI AND NEED FOR DIALYSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS Gastroenterology 2021, 160: in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation](http://www.ncbi.nlm.nih.gov/pubmed/33771685)Kaplan D, Mehta Garcia-Tsao G, Albrecht J, Aytaman A, Baffy G, Bajaj J, Hernaez R, Hunt K, Ioannou G, Johnson K, Kanwal F, Lee T, Monto A, Pandya P, Schaubel T. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events Mortality and Readmissions Over 90 Days Regardless of COVID19: A Multicenter Cohort](http://www.ncbi.nlm.nih.gov/pubmed/33427401)Bajaj GarciaTsao G, Wong F, Biggins SW, Kamath PS, McGeorge S, Chew M, Pearson M, Shaw J, Kalluri A, Fagan A, Olofson A, Moini M, de la Rosa Rodriguez R, Reddy KR. Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID19: A Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/33681681)Balakrishnan M, Falker C, Conley S, Ciarleglio M, Deng Y, Redeker NS, GarciaTsao G. Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases](http://www.ncbi.nlm.nih.gov/pubmed/33219529)Northup PG, GarciaPagan J, GarciaTsao DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Indicator of ProcedureRelated Bleeding in Decompensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/33553974)Zanetto A, Rinder HM, Senzolo M, Simioni P, GarciaTsao G. Reduced Clot Stability by Thromboelastography as a Potential Indicator of ProcedureRelated Bleeding in cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension](http://www.ncbi.nlm.nih.gov/pubmed/33210815)Saffo S, GarciaTsao G, Taddei T. SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension Journal Of Diabetes 2020, 13: Ascites Peripheral and PostPandemic Era: Challenges and the Need for Innovation](http://www.ncbi.nlm.nih.gov/pubmed/32740969)Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, GarciaTsao G, Terrault N, Lok AS, Chung RT, Reddy KR. Clinical Research in Hepatology in the COVID19 Pandemic and PostPandemic Era: Challenges and in patients with cirrhosis: a systematic review](http://www.ncbi.nlm.nih.gov/pubmed/32998172)Rabiee A, Ximenes R, Nikayin S, Hickner A, Juthani P, Rosen RH, GarciaTsao G. Factors associated with healthrelated quality of life in patients with cirrhosis: a systematic review Liver Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations Journal Of and Hypercoagulable Features](http://www.ncbi.nlm.nih.gov/pubmed/32614088)Zanetto Rinder HM, Campello M, Gavasso S, Bulato C, P, GarciaTsao G. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Jiang Lang S, Duan Y, Zhang X, Gao B, Chopyk J, Schwanemann LK, VenturaCots M, Bataller R, BosquesPadilla Brown RS, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross DL, Ho XM, P, Pride D, Fouts DE, Schnabl B. Intestinal Virome in Patients is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis](https://doi.org/10.1016/s0168-8278(20)30921-1)Zanetto A, Rinder H, Deng Y, Ciarleglio M, Wilson F, Bulato C, Simioni P, Garcia-Tsao G. THU137 Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated 1b acute kidney injury in cirrhosis is likely due to underlying chronic kidney disease and would be more appropriately re-classified as acute-on-chronic kidney disease](https://doi.org/10.1016/s0168-8278(20)30623-1)Wong F, Reddy S, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas H, Subramanian R, Thuluvath P, Kamath P, Thacker L, Bajaj J. AS044 Stage 1b acute kidney injury in cirrhosis is likely due to underlying chronic kidney disease and would be more appropriately re-classified as acute-on-chronic kidney disease Journal delivered by continuous intravenous infusion in patients with cirrhosis refractory Fagan A, Fischer J, Garcia-Tsao G, Angeli P, Smith D, Adams J, Markham P. SAT139 Safety, tolerability, pharmacokinetics and pharmacodynamic activity of terlipressin delivered by continuous intravenous infusion in patients with cirrhosis and refractory ascites: a [Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/32687928)Bajaj JS, Reddy KR, O'Leary JG, Vargas HE, Lai Tandon P, Wong F, Subramanian RM, Thuluvath P, Fagan A, White MB, Gavis EA, T, la Rodriguez M, Garcia-Tsao G, Gillevet PM. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/31837238)D'Amico G, Abraldes JG, Rebora P, Valsecchi MG, GarciaTsao G. Ordinal Outcomes Are Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis An Emerging Tool for Liver Education and IS ASSOCIATED WITH REVERSIBLE PLATELET DYSFUNCTION IN HOSPITALIZED PATIENTS WITH DECOMPENSATED CIRRHOSIS.](https://doi.org/10.1016/s0016-5085(20)33914-7)Zanetto A, Rinder H, Deng Y, Ciarleglio M, Wilson F, Bulato C, Simioni P, Garcia-Tsao G. 1002 ACUTE KIDNEY INJURY IS ASSOCIATED WITH REVERSIBLE PLATELET DYSFUNCTION IN HOSPITALIZED PATIENTS s-1301. [DOI: DEMONSTRATE BETTER PREDICTION FOR 90-DAY READMISSION AND DEATH IN WOMEN THAN MEN WITH CIRRHOSIS.](https://doi.org/10.1016/s0016-5085(20)33859-2)Saboo K, Hu C, Reddy K, O'Leary J, Tandon P, Wong F, Garcia-Tsao G, Kamath P, Lai J, Biggins S, Fallon M, Thuluvath P, Subramanian R, Maliakkal B, Vargas H, Thacker L, Iyer R, Bajaj J. 458 ARTIFICIAL INTELLIGENCE TECHNIQUES DEMONSTRATE BETTER PREDICTION FOR 90-DAY READMISSION AND DEATH IN WOMEN THAN 158: s-1279. [DOI: 10.1016/s0016-5085(20)33859-2](https://doi.org/10.1016/s0016-5085(20)33859-2). IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN PATIENTS WITH COMPENSATED CIRRHOSIS.](https://doi.org/10.1016/s0016-5085(20)34131-7)Ortiz G, Palumbo C, Sayyar M, Balakrishnan M, Mohanty A, Garcia-Tsao G. Su1696 SPLEEN STIFFNESS MEASUREMENTS (SSM) IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN 158: s-1385. [DOI: 10.1016/s0016-5085(20)34131-7](https://doi.org/10.1016/s0016-5085(20)34131-7). [Su1678 IMPACT OF RACE AND ETHNICITY ON OUTCOMES IN A MULTI-CENTER NORTH AMERICAN COHORT OF INPATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(20)32229-0)Bajaj J, O'Leary J, Tandon P, Wong F, Garcia-Tsao G, Kamath P, Lai J, Biggins S, Fallon M, Maliakkal B, Subramanian R, Thuluvath P, Vargas H, Thacker L, Reddy K. Su1678 IMPACT OF RACE AND ETHNICITY ON OUTCOMES IN A MULTI-CENTER NORTH AMERICAN COHORT OF Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum](http://www.ncbi.nlm.nih.gov/pubmed/32353369)Noureddin M, Chan J, Barradas K, Dimick-Santos L, Schabel E, Omokaro S, Anania F, Myers R, Miller V, Sanyal A, Chalasani N, Group L, Anania F, Bajaj J, Brower A, Calboli D, Chalasani N, Chan J, Charlton W, Dickinson K, Dimick-Santos L, Filozof C, Forsgren M, Fuchs G, Gonzalez-Abraldes J, Gruss H, Hansen M, Hosman S, Imperial J, Jones D, Lalazar G, Leinhard O, Lyons E, McColgan B, Mehta R, Mesenbrink P, Miller V, Myers R, Noureddin M, Omokaro S, Pei V, Ratziu V, Regev A, Riccio R, Sanyal A, Schabel E, Seo S, A, Szitanyi P, Traber P. Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From is reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis](https://doi.org/10.1016/j.dld.2019.12.031)Zanetto A, Rinder H, Deng Y, Ciarleglio M, Wilson F, Bulato C, Simioni P, Garcia-Tsao G. Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis Disease 2020, 52: to Letter 'Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient'](http://www.ncbi.nlm.nih.gov/pubmed/31749290)Ortiz GA, Sayyar M, GarciaTsao G. Author response to Letter to the Editor: 'Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous GarciaTsao G. Prophylactic Antibiotics in Cirrhosis: Are They Promoting or Preventing Infections? after viral elimination in chronic HCV, independent of the presence or absence of cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/31365178)Sayyar M, Saidi M, Zapatka S, Deng Y, Ciarleglio M, GarciaTsao G. Platelet count increases after viral elimination in chronic HCV, independent of the presence or absence of cirrhosis Response to Fungi in Patients With Alcoholic Hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/31228214)Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, VenturaCots M, Abraldes JG, BosquesPadilla F, Verna EC, Brown RS, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross D, Lucey MR, DE, Schnabl B. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis Kamath PS, Bajaj JS, for the Study of the Liver F. Reply Transplantation 2019, 25: Patients with Hepatic Encephalopathy in a Large Multi-Center Cohort](https://doi.org/10.1016/s0016-5085(19)38297-6)Bajaj J, Tandon Wong F, Garcia-Tsao G, Biggins S, Kamath P, Thuluvath P, Lai J, Vargas H, Subramanian R, Maliakkal B, Fallon M, Thacker L, Reddy K. Su1527 - Potentially Preventable Readmissions and Complications in Hospitalized Patients with Hepatic Encephalopathy Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients with Alcoholic Hepatitis](https://doi.org/10.1016/s0016-5085(19)39939-1)Lang S, Duan Y, Liu J, Ventura-Cots M, Lucey M, Padilla F, Mathurin P, Louvet A, Garcia-Tsao G, Verna E, Abraldes J, Brown R, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross D, Ho S, Bataller R, Tu X, St\u00e4rkel P, Fouts D, Schnabl B. 246 - Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients with Alcoholic Hepatitis Gastroenterology 2019, 156: s-1186. [DOI: 10.1016/s0016-5085(19)39939-1](https://doi.org/10.1016/s0016-5085(19)39939-1). [573 - Predictive Factors for the Development of Acute-Onchronic Liver Failure in a North American Cohort of Hospitalized Cirrhotic Patients with Decompensation](https://doi.org/10.1016/s0016-5085(19)39995-0)Wong F, Reddy K, Tandon P, O'Leary J, Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian P, Thacker L, Bajaj J. 573 - Predictive Factors for the Development of Acute-Onchronic Liver Failure in a North American Cohort of Hospitalized Cirrhotic Patients with Decompensation Wong F, Kamath P, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas H, Thuluvath P, Subramanian R, Thacker - The Natural Histyory of Stages 2 & 3 Acute Kidney Injury (AKI) in Patients with Decompensated Cirrhosis and Ascites](https://doi.org/10.1016/s0016-5085(19)40399-5)Wong F, Reddy K, Tandon P, O'Leary Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian L, Bajaj J. Tu1519 - The Natural Histyory of Stages 2 & 3 Acute Kidney Injury (AKI) in Patients with Decompensated of care hepatic encephalopathy: data from a multicentre cohort](http://www.ncbi.nlm.nih.gov/pubmed/31032966)Bajaj Wong SW, GarciaTsao G, Lai J, Fallon MB, B, Subramanian RM, Thacker LR, Reddy KR. Targets to improve quality of care for patients with hepatic encephalopathy: data from a SW, GarciaTsao PJ, Kamath PS, Thacker L, Bajaj JS. Impact of Chronic Kidney Disease on Outcomes in Liver Transplantation 2019, Wong F, Garcia-Tsao G, Kamath P, Maliakkal B, Lai J, Fallon M, Thuluvath P, Subramanian R, Vargas H, Thacker of hospice in inpatients in a large multi-center cohort](https://doi.org/10.1016/s0618-8278(19)31256-3)Bajaj J, Tandon Wong F, Garcia-Tsao G, Biggins S, Kamath P, Thuluvath P, Lai J, Vargas H, Subramanian R, M, Thacker L, Reddy R. and complications in hospitalized patients with hepatic encephalopathy in a large multi-center 70: e630-e631. [DOI: 10.1016/s0618-8278(19)31256-3](https://doi.org/10.1016/s0618-8278(19)31256-3). [SAT-140-The natural history of stages 2 and 3 acute kidney injury in hospitalized patients with decompensated cirrhosis and ascites](https://doi.org/10.1016/s0618-8278(19)31379-9)Wong F, Reddy R, Tandon P, O'leary Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian P, Thacker L, Bajaj J. SAT-140-The natural history of stages 2 and 3 acute kidney injury in hospitalized patients with decompensated cirrhosis and [SAT-139-Predictive factors for the development of acute-on-chronic liver failure in a North American cohort of hospitalized patients with cirrhosis and decompensation](https://doi.org/10.1016/s0618-8278(19)31378-7)Wong F, Reddy R, Tandon P, O'leary J, Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian P, Thacker L, Bajaj J. SAT-139-Predictive factors for the development of acute-on-chronic liver failure in a North American cohort of hospitalized patients with cirrhosis and decompensation cirrhosis and severe portal hypertension](https://doi.org/10.1016/s0618-8278(19)30225-7)Garcia-Tsao G, Bosch J, Kayali Z, Harrison S, Abdelmalek M, Lawitz E, Satapathy S, Ghabril M, Shiffman M, Younes Z, Thuluvath P, Berzigotti A, Albillos A, Robinson J, A. LBO-01-Multicenter, double-blind, placebo-controlled, randomized trial of emricasan in subjects with NASH cirrhosis and severe portal hypertension Journal Of Hepatology 2019, 70: e127. [DOI: 10.1016/s0618-8278(19)30225-7](https://doi.org/10.1016/s0618-8278(19)30225-7). [Outcomes After Listing for Transplant in Patients With AcuteonChronic Liver Failure: The Multicenter North American Consortium for the Study of EndStage Liver Disease Experience](http://www.ncbi.nlm.nih.gov/pubmed/30724010)O'Leary J, Bajaj JS, Tandon Wong PS, GarciaTsao G, Maliakkal B, Lai J, Fallon HE, Thuluvath P, Subramanian R, Thacker LR, Reddy K. Outcomes After Listing for Liver Transplant in Patients With AcuteonChronic Liver Failure: The Multicenter North American Consortium for the Study of EndStage Liver Disease Experience Liver Transplantation 2019, Font C, del Carmen D\u00edaz-Pedroche M, Mazzolai L, Little D, Tufano A, Siegal D, Lip G, Monreal M. VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY Journal Of The American College Of Cardiology 2019, 2043. [DOI: 10.1016/s0735-1097(19)32649-x](https://doi.org/10.1016/s0735-1097(19)32649-x). Rockey DC, Shah VH, Bosch J, GarciaTsao G. Prioritization of Therapeutic Targets and Trial Design in GarciaTsao G. AcuteonChronic Liver Failure: An Old Entity in Search of Clarity With Compensated Cirrhosis and Severe Portal Hypertension](http://www.ncbi.nlm.nih.gov/pubmed/30063802)GarciaTsao G, Fuchs Hagerty DT, Bosch J. Emricasan (IDN6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation \"Postparacentesis hemoperitoneum time to become more careful!\"](http://www.ncbi.nlm.nih.gov/pubmed/30145847)Hung A, GarciaTsao G. Author response to Letter to the Editor \"Postparacentesis hemoperitoneum time to become more Platelet Count Increases Viral in Chronic HCV, Independent of Fibrosis Stage](https://doi.org/10.1016/s0016-5085(18)34092-7)Sayyar M, Saidi M, Zapatka Y, Ciarleglio M, Garcia-Tsao G. Tu1542 - Platelet Count Increases after Viral Suppression in Chronic HCV, Independent Fibrosis Stage Gastroenterology 2018, 154: s-1245-s-1246. [DOI: [Tu1543 - of Repeat Liver Stiffness Measurements (LSM) by Transient Elastography (TE) and LSM by Acoustic Radiation Force Impulse (ARFI) in the Clinical Evaluation of Cirrhosis in Patients in whom Initial TE is Equivocal](https://doi.org/10.1016/s0016-5085(18)34093-9)Sayyar M, de Oliveira A, Jangouk P, Bernardo A, Garcia-Tsao G. Tu1543 - Usefulness of Repeat Liver Stiffness Measurements (LSM) by Transient Elastography (TE) and LSM by Acoustic Radiation Force Impulse (ARFI) in the Clinical Evaluation of Cirrhosis in Patients in whom Initial TE is Equivocal Gastroenterology 154: s-1246. [DOI: 10.1016/s0016-5085(18)34093-9](https://doi.org/10.1016/s0016-5085(18)34093-9). [499 - Primary SBP Prophylaxis is Associated with Higher ICU Admission and 30-Day Mortality Compared to Secondary SBP Prophylaxis](https://doi.org/10.1016/s0016-5085(18)33633-3)Bajaj J, O'Leary J, Tandon P, Kamath P, Wong F, Garcia-Tsao G, Lai J, Thuluvath P, Subramanian R, Vargas H, Fallon M, Thacker L, Reddy K. 499 - Primary SBP Prophylaxis is Associated with Higher ICU Admission and 30-Day Mortality Compared to Secondary SBP Prophylaxis Gastroenterology Acid Reduces Bacterial Translocation to Extra-Intestinal Sites and has a Beneficial Intrahepatic Effect](https://doi.org/10.1016/s0016-5085(18)33897-6)Hung A, Yan K, Yang H, Jain D, Garcia-Tsao G. Su1556 - In Experimental Cirrhosis with Ascites, Obeticholic Acid Reduces Bacterial Translocation to Extra-Intestinal Sites and patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/29315693)O'Leary JG, Reddy KR, GarciaTsao G, Biggins Kamath PS, Thuluvath P, Vargas failure prophylaxis is associated with greater ICU admission and 30-day mortality compared to secondary spontaneous bacterial peritonitis prophylaxis](https://doi.org/10.1016/s0168-8278(18)30353-2)Bajaj J, Tandon P, O'leary J, Wong G, Kamath P, Maliakkal B, Fallon M, Thuluvath P, Lai J, Subramanian R, Vargas H, Thacker L, Reddy R. GS-015 Primary spontaneous bacterial peritonitis prophylaxis is associated with greater ICU admission and 30-day mortality compared to secondary spontaneous bacterial peritonitis prophylaxis 13C-methacetin breath test is a highly accurate non-invasive point of care test for detecting CSPH in patients with NASH](https://doi.org/10.1016/s0168-8278(18)30446-x)Bosch J, Bureau C, Chalasani N, Lawitz E, Abdelmalek M, Rinella M, Harrison S, Berzigotti A, Sanyal A, Noureddin M, Rockey D, Ber T, Ilan Y, Garcia-Tsao G. LBP-019 13C-methacetin breath test is a highly accurate non-invasive point of care test for detecting CSPH in patients with NASH Journal Of NASH cirrhosis and portal hypertension](https://doi.org/10.1016/s0168-8278(18)30420-3)Chalasani N, Garcia-Tsao G, Goodman Z, Lawitz E, Abdelmalek M, Rinella M, Ryan M, Noureddin M, Jue C, Pyko M, Allgood A, Shlevin E, Traber P, Loomba R, in with NASH cirrhosis and Of Hepatology 2018, 68: 10.1016/s0168-8278(18)30420-3](https://doi.org/10.1016/s0168-8278(18)30420-3). - [DOI: 10.1007/978-3-319-72628-1_1](https://doi.org/10.1007/978-3-319-72628-1_1). [THREE TYPES OF INTRAHEPATIC SHUNTS PRESENTING PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA](https://doi.org/10.1016/s0735-1097(18)32934-6)Brandt E, Haghighat L, Garcia-Tsao G, Henderson K, Pollak J, Proctor D, Young L. THREE TYPES OF INTRAHEPATIC SHUNTS PRESENTING IN A SINGLE PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA Journal Of The American College Of Cardiology 2018, 71: a2393. [DOI: 10.1016/s0735-1097(18)32934-6](https://doi.org/10.1016/s0735-1097(18)32934-6). [Acute kidney injury, but not sepsis, is associated with higher procedurerelated bleeding in patients with decompensated cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/29393567)Hung A, GarciaTsao G. Acute kidney injury, but not sepsis, is associated with higher procedurerelated bleeding in patients with decompensated the New Hepatitis C Antiviral Medications: 'A New Lease on Life'](https://doi.org/10.46743/2160-3715/2018.2740)Giordano N, Brinn A, Garcia-Tsao G, Martino S. Patient Perspectives on Adherence to the New Hepatitis C Antiviral Medications: 'A New Lease on Life' The Qualitative Report 2018 [DOI: 10.46743/2160-3715/2018.2740](https://doi.org/10.46743/2160-3715/2018.2740). - 10.1016/b978-0-323-37591-7.00015-x](https://doi.org/10.1016/b978-0-323-37591-7.00015-x). in hospitalised patients with mortality and factors determining discontinuation and reinitiation](http://www.ncbi.nlm.nih.gov/pubmed/28994122)Bhutta A, GarciaTsao G, Reddy K, Tandon P, Wong F, O'Leary J, Acharya C, Banerjee D, Abraldes J, Jones T, Shaw J, Deng Y, Ciarleglio M, Bajaj J. Betablockers in hospitalised patients with cirrhosis and ascites: mortality and recurrent variceal hemorrhage: Results of an individual patient metaanalysis](http://www.ncbi.nlm.nih.gov/pubmed/28543862)Albillos A, Zamora J, Mart\u00ednez J, Arroyo D, Ahmad I, DelaPe\u00f1a J, GarciaPag\u00e1n J, Lo G, Sarin S, Sharma B, Abraldes JG, Bosch J, GarciaTsao G, Cooperation O. Stratifying risk in the prevention of recurrent variceal hemorrhage: Results B, Tandon P, Vargas H, Thacker L, Bajaj J. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes Deng Y, Garcia-Tsao G. Reply to Risk Stratification in Acute Variceal Bleeding Nacseld Cirrhotic Patients](https://doi.org/10.1016/s0016-5085(17)33569-2)O'Leary J, Reddy K, Tandon P, Kamath P, Wong Garcia-Tsao G, Lai J, Biggins S, Fallon M, Subramanian Nacseld Liver Tandon P, Biggins S, Kamath P, Lai J, Subramanian R, Fallon M, Maliakkal B, H, Thuluvath P, Thacker L, Reddy K. Tu1549 Albumin Use and Acute Kidney Injury in and secondary prophylaxis of esophageal variceal bleeding highrisk varices in patients with compensated cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/28160373)Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, GarciaTsao G. Validating, deconstructing and refining Baveno criteria for ruling out highrisk varices in patients fibrosis and cirrhosis, early decline of liver stiffness following antiviral therapy with DAAs is related to decline in liver inflammation](https://doi.org/10.1016/s0168-8278(17)30876-0)Winters A, Luedtke S, Moreland A, Jangouk P, Weng G, Silveira M, Davitkov P, Duarte-Rojo A, Cheung R, Garcia-Tsao G, Falck-Ytter Y, Branch A, Br\u00e4u N. THU-209 In hepatitis C virus-related advanced fibrosis and cirrhosis, early decline of liver stiffness following antiviral therapy with DAAs is related to decline in liver inflammation Journal Of Hepatology 2017, 66: venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysis](https://doi.org/10.1016/s0168-8278(17)30468-3)Turco L, Villanueva C, La Mura J, Reiberger T, Genesca J, Groszmann R, Sharma B, Merkel C, Bureau C, Alvarado E, Abraldes J, Albillos A, Banares R, Peck-Radosavljevic S, G. A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated clinically significant portal hypertension in patients with NASH cirrhosis](https://doi.org/10.1016/s0168-8278(17)30461-0)Ilan Y, Harrison S, Traber P, Chalasani N, Garcia-Tsao G. LBP-516 13C-Methacetin Breath Test accurately assesses clinically significant portal hypertension in patients with NASH cirrhosis Of Tandon P, Biggins S, Kamath P, Lai J, Fallon M, Subramanian R, Maliakkal B, Thuluvath P, Vargas H, Thacker L, Reddy R, Disease N. FRI-025 Albumin use and acute kidney injury in a large real-world analysis of diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases](http://www.ncbi.nlm.nih.gov/pubmed/27786365)GarciaTsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases discharge in patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/27775842)Tandon P, Reddy KR, O'Leary JG, GarciaTsao N. A Karnofsky performance status-based score predicts death after hospital discharge in Francoz C, Garcia-Tsao G, Gin\u00e8s P, Ison MG, Kramer DJ, Mehta RL, Moreau R, JC, critically cirrhosis: A multidisciplinary in patients with cirrhosis and ascites: type [PMID: 27207973](https://pubmed.ncbi.nlm.nih.gov/27207973), [DOI: 10.1136/gutjnl-2016-312129](https://doi.org/10.1136/gutjnl-2016-312129). [AISF position paper on liver transplantation and pregnancy Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)](http://www.ncbi.nlm.nih.gov/pubmed/27267817)Alisi A, Balsano C, Bernabucci V, Berzigotti E, Coco B, Colle I, Critelli R, De Martin E, Del Buono M, Fabregat I, Faillaci F, Fattovich G, Floreani G, Smedile A, Burra P, Rodr\u00edguez-Castro K, Guarino M, Morisco F, Villa E, Mazzella G. AISF position paper on liver transplantation and pregnancy Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) Digestive And Spontaneous Bacterial Peritonitis (SBP): Incidence, Risk Factors, Clinical Impact, and Antibiotic Choices](https://doi.org/10.1016/s0016-5085(16)33749-0)To U, Delisle A, Garcia-Tsao G. Su1493 Non-Response to Empirical Treatment for Spontaneous Bacterial Peritonitis (SBP): Incidence, Risk Factors, Clinical Impact, and 150: Patients With Ascites Is Associated With a Lower MELD, Less Inflammation and an Improved Survival](https://doi.org/10.1016/s0016-5085(16)33659-9)Bhutta A, Garcia-Tsao G, Reddy K, Tandon P, Wong J, Acharya C, Banerjee D, Abraldes J, Plener I, Jones T, Shaw J, Deng Y, Ciarleglio M, Bajaj J. Sa1645 Beta-Blocker (BB) Use in Hospitalized Cirrhotic Patients With Ascites Is Associated With a Lower MELD, Less Inflammation and an Improved Survival Gastroenterology 2016, 150: ACLF and Varies Significantly Across America: NACSELD Experience](https://doi.org/10.1016/s0016-5085(16)33769-6)Bajaj J, Reddy K, Tandon S, Fallon M, Maliakkal B, Thuluvath P, Subramanian R, H, Lai J, Thacker L, O'Leary J. Su1513 In-Hospital Mortality Related to Hepatic Encephalopathy Is Independent of ACLF and Varies Significantly 150: s1117. [DOI: Mortality After Discharge From Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score](https://doi.org/10.1016/s0016-5085(16)33906-3)Tandon P, Reddy K, O'Leary J, Garcia-Tsao P, Thacker L, Bajaj J. Tu1649 Predicting Mortality After Discharge From Hospital in Cirrhosis: A Prospective Assessment of the unacceptably high in a large North American cohort of patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/26690389)Bajaj JS, Reddy KR, Tandon Biggins SW, RM, LR, JG, Disease N. The 3month readmission rate remains unacceptably high in a large North American cohort of patients and Its Complications 2016, 447-458. [DOI: 10.1002/9781118512104.ch55](https://doi.org/10.1002/9781118512104.ch55). [THU-001 Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with a Lower Meld, less Inflammation and an Improved Survival](https://doi.org/10.1016/s0168-8278(16)00253-1)Bhutta A, Garcia-Tsao G, Reddy R, Tandon P, Wong J, Acharya C, Banerjee D, Abraldes J, Plener I, Jones T, Shaw J, Deng Y, Ciarleglio M, Bajaj J. THU-001 Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with a Lower Meld, less Inflammation and an Improved Survival Journal Of Hepatology 2016, 64: s245. [DOI: 10.1016/s0168-8278(16)00253-1](https://doi.org/10.1016/s0168-8278(16)00253-1). [THU-373 Predicting Mortality after Discharge from Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score](https://doi.org/10.1016/s0168-8278(16)00340-8)Tandon P, Reddy R, O'Leary J, Garcia-Tsao P, Thacker L, Bajaj J. THU-373 Predicting Mortality after Discharge from Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score Journal Of Hepatology 2016, 64: s282. [DOI: of Current Therapies at Variceal Rebleeding on Other Complications of Cirrhosis](https://doi.org/10.1007/978-3-319-23018-4_33)Ripoll C, Augustin S, Reiberger T, Moreau R, Salerno F, Albillos A, Abraldes J, Garcia-Tsao G. Effect of Current Therapies Aimed at Preventing Variceal Rebleeding on Other Complications of Cirrhosis Augustin Salerno F, Moreau R, Reiberger T, Garcia-Tsao G. Impact of Treatment of Non-bleeding Complications of Cirrhosis on the Risk of Variceal Bleeding 341-353. Albillos A, Moreau R, Salerno F, Abraldes J. Introduction and Survey Results 2016, 303-309. [DOI: 10.1007/978-3-319-23018-4_30](https://doi.org/10.1007/978-3-319-23018-4_30). Abraldes T, Ripoll C, F, Garcia-Tsao G. Consensus Statements: Preventing Recurrent Hemorrhage S, Salerno F, Abraldes J, Garcia-Tsao G. Secondary Prophylaxis in Special Patient Populations 317-332. 10.1007/978-3-319-23018-4_32](https://doi.org/10.1007/978-3-319-23018-4_32). A, Abraldes Augustin S, R, G. Prevention of 2016, 311-316. [THU-347 Progressive Alterations in Systemic and Cardiopulmonary Hemodynamics Occur in Patients with Cirrhosis and Predict Death in Decompensated Cirrhosis](https://doi.org/10.1016/s0168-8278(16)00314-7)Turco L, Garcia-Tsao G, Magnani I, Bianchini M, Costetti M, Rossi R, Villa E, Schepis F. THU-347 Progressive Alterations in Systemic and Cardiopulmonary Hemodynamics Occur in Patients with Cirrhosis and Predict Death in Cirrhosis Reiberger T, Moreau R, Albillos A, Garcia-Tsao G. Issues in Trial Design and Areas Needing Further Research 2016, 355-363. [DOI: 10.1007/978-3-319-23018-4_35](https://doi.org/10.1007/978-3-319-23018-4_35). - GarciaTsao [DOI: 10.1002/9781118512074.ch106](https://doi.org/10.1002/9781118512074.ch106). [Corrigendum to \"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites\" [J Hepatol 2015;62:968-974]](https://doi.org/10.1016/j.jhep.2015.04.001)Angeli P, Gin\u00e8s P, Wong T, Gerbes A, Moreau R, Jalan R, Sarin S, Piano S, Moore K, Lee S, Durand F, Salerno F, Caraceni P, Kim W, Arroyo V, Garcia-Tsao G. Corrigendum to \"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites\" [J Hepatol 10.1016/j.jhep.2015.04.001](https://doi.org/10.1016/j.jhep.2015.04.001). [High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of endstage liver disease](http://www.ncbi.nlm.nih.gov/pubmed/25845966)Reddy KR, O'Leary JG, Kamath RM, Thacker LR, Bajaj JS, Disease F. High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of endstage liver disease Liver Transplantation 2015, 21: 881-888. [PMID: : The a large multi-center cohort of cirrhotic patients](https://doi.org/10.1016/s0168-8278(15)30340-8)Bajaj J, Reddy K, Garcia-Tsao B, Kamath L, of O. P0120 : The 3-month readmission rate remains unacceptably high in a large multi-center cohort of cirrhotic patients Journal Of Hepatology 2015, P, Vargas H, Thacker L, Bajaj J. Mo1892 Acute Kidney Injury in Cirrhosis: Multi-Center Cohort of Cirrhotic Patients](https://doi.org/10.1016/s0016-5085(15)33360-6)Bajaj J, Reddy K, Garcia-Tsao B, Kamath J. 575 The 3-Month Readmission Rate Remains Unacceptably High in a Large cohort](https://doi.org/10.1016/s0168-8278(15)30339-1)O'Leary J, Reddy K, Garcia-Tsao G, Biggins J, Of The NACSELD Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) score in an (I-ACLF) Definition for 30-Day Mortality Prediction in Infected and Uninfected Hospitalized Cirrhotic Patients](https://doi.org/10.1016/s0016-5085(15)33376-x)O'Leary J, Reddy K, Garcia-Tsao G, Biggins Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) Definition for 30-Day Mortality Prediction in Infected and Uninfected Hospitalized Cirrhotic Patients Gastroenterology 2015, 148: use decreases and death in veterans with hepatitis C-related compensated cirrhosis](https://doi.org/10.1016/s0168-8278(15)30086-6)Mohanty A, Tate J, Garcia-Tsao G. O072 : Statin use significantly decreases decompensation and death in veterans with hepatitis C-related compensated cirrhosis Journal Of Hepatology 2015, B, Tandon P, Vargas H, Thacker L, Bajaj J, Disease N. P0199 : Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient 10.1016/s0168-8278(15)30418-9](https://doi.org/10.1016/s0168-8278(15)30418-9). [231/356 Statin Use and the Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis](https://doi.org/10.1016/s0016-5085(15)33322-9)Mohanty A, Tate J, Garcia-Tsao G. 231/356 Statin Use and the Risk of Decompensation and Death in Veterans With Hepatitis C-Related H, Ansari N, Coca SG, GarciaTsao G, Parikh CR, Consortium F. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute R, Subramanian RM, LR, Kamath PS, Disease T. Survival in infectionrelated acuteonchronic liver failure is defined by 13: 171-179. [DOI: Intra-and Inter-Observer Variability Munoz C, Augustin S, Loo N, Deng Y, Ciarleglio M, Garcia-Tsao G. Sa1004 Measurement of Liver and Associated With Sustained Virological Response in Patients With Hepatitis C Treated With Pegylated Interferon and Ribavirin, Independent of Host Metabolic Factors](https://doi.org/10.1016/s0016-5085(14)63541-1)Sanchez M, Augustin S, Balakrishnan M, Re V, Tate J, Garcia-Tsao G. Su1050 Statin Use Is Associated With Sustained Virological Response in Patients With Hepatitis C Treated With Pegylated Interferon and Ribavirin, Independent of 10.1016/s0016-5085(14)63541-1](https://doi.org/10.1016/s0016-5085(14)63541-1). Cirrhotic Women: The Nacseld Experience](https://doi.org/10.1016/s0016-5085(14)63596-4)O'Leary J, Wong S, Fallon B, R, Thacker L, Bajaj J. Mo1027 Differences in Creatinine Between Genders Could Disadvantage INTRA- AND INTER-OBSERVER VARIABILITY Souza F, Munoz C, Augustin S, Loo N, Deng Y, Ciarleglio M, Garcia-Tsao G. P1013 MEASUREMENT OF LIVER AND SPLEEN BY ELASTOGRAPHY: INTRA- AND INTER-OBSERVER DESPITE PROPHYLACTIC MEASURES: PROSPECTIVE MULTI-CENTER STUDY FROM NACSELD](https://doi.org/10.1016/s0168-8278(14)60664-4)Biggins O'Leary Reddy K, Wong Kamath M, Garcia-Tsao G, Subramanian R, Thuluvath P, Maliakkal B, Koch D, Malik R, Thacker L, Bajaj J. P502 SPONTANEOUS BACTERIAL PERITONITIS AND BACTEREMIA MORTALITY IN CIRRHOSIS DESPITE PROPHYLACTIC MEASURES: A PROSPECTIVE 10.1016/s0168-8278(14)60664-4](https://doi.org/10.1016/s0168-8278(14)60664-4). WOMEN: THE NACSELD EXPERIENCE](https://doi.org/10.1016/s0168-8278(14)61104-1)Bajaj J, O'Leary S, Patton H, Maliakkal B, Thuluvath G, D, Thacker L, Kamath P. P943 DIFFERENCES IN CREATININE BETWEEN GENDERS COULD DISADVANTAGE INFECTED CIRRHOTIC WOMEN: THE Journal Of Groszmann Stalling C, Grace ND, Burroughs AK, Patch D, Matloff DS, Clopton P, Chojkier M. Novel inflammatory biomarkers of portal pressure new onset ascites: A diagnostic accuracy study](http://www.ncbi.nlm.nih.gov/pubmed/23907731)Farias AQ, Silvestre peptide the initial workup of patients with new onset ascites: A diagnostic [DOI: 10.1002/hep.26643](https://doi.org/10.1002/hep.26643). [New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection](http://www.ncbi.nlm.nih.gov/pubmed/23999172)Wong F, O'Leary B, Thacker LR, Bajaj JS, Disease N. New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and ascites analyses in the diagnosis of ascites related to heart failure](https://doi.org/10.1093/eurheartj/eht309.p4241)Farias A, Silvestre O, Bacal peptide is more accurate than ascites analyses in the diagnosis of ascites related to heart failure European Heart Journal 2013, 34: p4241-p4241. [DOI: 10.1093/eurheartj/eht309.p4241](https://doi.org/10.1093/eurheartj/eht309.p4241). - Fortune BE, GarciaTsao G. Hypervolemic hyponatremia: Clinical significance and management Clinical [PMID: 30992838](https://pubmed.ncbi.nlm.nih.gov/30992838), [PMCID: PMC6448632](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448632), [DOI: 10.1002/cld.179](https://doi.org/10.1002/cld.179). [Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary GarciaTsao G. Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations Image Analysis Can Predict Hpvg and Help in Sub-Classification of Cirrhosis](https://doi.org/10.1016/s0016-5085(13)63404-6)Alduaij A, Jain D, A, Demetris A, G, Scott R. Tu2048 Histological Features Using Quantitative Morphometric Digital Image Analysis Can Predict Hpvg and Help Acute Kidney Injury in Patients With Cirrhosis: Perils and Promise Clinical Lim JK, Ansari N, Coca SG, Parikh CR, Consortium F. Association of AKI With mortality and complications in hospitalized patients with the Spleen Gets Tough, the Among Patients With Cirrhosis at a US Liver Center](http://www.ncbi.nlm.nih.gov/pubmed/22902776)Tandon P, DeLisle A, Topal JE, Garcia-Tsao G. High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center Clinical Not Superior to Albumin in Preventing Recurrence of Ascites After Large-Volume Paracentesis](http://www.ncbi.nlm.nih.gov/pubmed/22801062)Bari H, D, Garcia-Tsao G. The Combination of Octreotide and Midodrine Is Not Superior to Albumin in Preventing Recurrence of Ascites After Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class](https://doi.org/10.1016/s0016-5085(12)63744-5)Bari K, Augustin S, Eggers C, Hashem H, Desai M, Shea M, Wongcharatrawee S, Lim J, Garcia-Tsao G. Sa1091 Hepatitis C (HCV) Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class Gastroenterology 2012, 142: s-967. [DOI: C, J, Richter J, Chan F. Functional Gastrointestinal Disease 2012, [The (EV), but not treatment with beta-blockers, is associated with a poorer survival in patients with cirrhosis and ascites](https://doi.org/10.1055/s-0031-1295840)Zipprich A, Garcia-Tsao G, Seufferlein T, Dollinger M. The presence of esophageal varices (EV), but not treatment with beta-blockers, is associated with a poorer survival in patients with cirrhosis and ascites Zeitschrift F\u00fcr Gastroenterologie 999-1007. [DOI: 10.1016/b978-1-4377-1604-7.00156-1](https://doi.org/10.1016/b978-1-4377-1604-7.00156-1). - Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, GarciaTsao G, Kamath PS. Intensive care of transplantation on the survival of patients treated for hepatorenal syndrome type 1*](http://www.ncbi.nlm.nih.gov/pubmed/21837734)Boyer TD, Sanyal AJ, GarciaTsao V, Sigal S, Bexon AS, Teuber P, Group T. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1* Burroughs AK, Morillas R, A, GarciaPagan J, Patch D, Matloff DS, Groszmann RJ, Group T. Obesity is an independent risk factor for clinical decompensation in patients 165-181. Garcia-Tsao G. Albilllos A, G. Classification of Cirrhosis: The Clinical Use of HVPG Measurements Disease Markers 2011, 31: 121-128. [DOI: 10.1155/2011/706032](https://doi.org/10.1155/2011/706032). [Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis](http://www.ncbi.nlm.nih.gov/pubmed/21145427)Tandon P, Garcia-Tsao G. Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis Lim J, Tandon P, Garcia-Tsao G. Antibiotic Prophylaxis and Management 2010, 395-410. [DOI: 10.1007/978-1-60761-866-9_20](https://doi.org/10.1007/978-1-60761-866-9_20). [Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/20492521)Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, GarciaTsao G, Lee SS. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis Liver International Beta-Blockers Protects Against Worsening of Thrombocytopenia in Cirrhosis](https://doi.org/10.1016/s0016-5085(10)63764-x)Qamar A, Grace N, Groszmann R, Garcia-Tsao G, Bosch J, Burroughs A, Iskandar H, Maurer R, Planas R, Escorsell A, Garcia-Pagan J, Patch D, Matloff D, Makuch R, From P. S1918 A Hemodynamic Response to Treatment With Non-Selective Beta-Blockers Protects s-817. [DOI: 10.1016/s0016-5085(10)63764-x](https://doi.org/10.1016/s0016-5085(10)63764-x). No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/20144739)Tandon P, Inayat I, Tal M, Spector M, Shea M, Groszmann RJ, Garcia-Tsao G. Sildenafil Has No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated Cirrhosis to Qi et al. The American Journal Of Gastroenterology 2010, 105: 472. [DOI: 10.1038/ajg.2009.628](https://doi.org/10.1038/ajg.2009.628). [Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/20077563)GarciaTsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological hemorrhage: And the winner is...](http://www.ncbi.nlm.nih.gov/pubmed/19714716)Bosch J, GarciaTsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program](https://doi.org/10.1038/ajg.2009.360)Garcia-Tsao G, Lim J. Erratum: Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program The American Journal Of Gastroenterology 2009, 104: ajg2009360. [DOI: 10.1038/ajg.2009.360](https://doi.org/10.1038/ajg.2009.360). With Acute Decompensation in Patients With Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/19394441)Khalid SK, Lane J, Navarro V, Garcia-Tsao G. Use of Over-the-Counter Analgesics Is Not Associated With Acute Decompensation in Patients A, 233 QUANTITATIVE HISTOLOGICAL ASSESSMENT CIRRHOSIS: s94. [DOI: 10.1016/s0168-8278(09)60235-x](https://doi.org/10.1016/s0168-8278(09)60235-x). [Incidence, Prevalence, and Clinical Significance of in Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/19281860)Qamar AA, Grace ND, Groszmann Planas R, Escorsell A, Garcia-Pagan J, Patch D, Matloff DS, Makuch R, Rendon G, Group P. Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis with Ascites and its Complications 2009, 103-113. Hepatic hereditary Combes B, Mills AS, Markin RS, Rubin R, Wheeler D, Contos M, West AB, Saldana S, Getachew Y, Butsch R, Luketic V, Peters M, Di Bisceglie A, Bass N, Lake J, Boyer T, Martinez E, Boyer J, GarciaTsao G, Barnes D, Rosenberg WM. Prediction of clinical outcomes in primary biliary cirrhosis Ascites and Its Complications 2008, 442-466. [DOI: 10.1002/9781444300758.ch23](https://doi.org/10.1002/9781444300758.ch23). [Portal hypertension and variceal bleeding\u2014Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver singletopic conference](http://www.ncbi.nlm.nih.gov/pubmed/18435460)GarciaTsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding\u2014Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver singletopic Syndrome](http://www.ncbi.nlm.nih.gov/pubmed/18471513)Sanyal Boyer T, Garcia-Tsao Regenstein B, Blei A, V, P, T. A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin Infections, Sepsis, and Multiorgan Failure in Cirrhosis Seminars In Liver INDICATORS STAGES OF LIVER CIRRHOSIS: VALIDATION OF A Rogowski S, Fleig W. 317 PROGNOSTIC INDICATORS OF SURVIVAL IN COMPENSATED AND DECOMPENSATED STAGES OF LIVER CIRRHOSIS: VALIDATION OF A count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/18161700)Qamar AA, Grace Escorsell A, GarciaPagan J, Patch D, Matloff DS, Makuch R, Group P. Platelet count is not a predictor of the presence or development of gastroesophageal project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage](http://www.ncbi.nlm.nih.gov/pubmed/17935182)Longacre AV, Imaeda A, GarciaTsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis and Hispanic patients with primary biliary cirrhosis in the United States](http://www.ncbi.nlm.nih.gov/pubmed/17654740)Peters MG, TD, Lake JR, Bonacini M, Combes B, Group P. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the Grace ND, Carey W, Diseases T. Prevention and management of gastroesophageal Patients With Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/17681169)Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan J, Makuch R, Patch D, Matloff DS, Bosch J, Group P. Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in J. Model for endstage liver disease (MELD) exception for hereditary hemorrhagic Sabb\u00e0 C, Miller F, Saurin JC, Pelage JP, Lesca G, Marion MJ, Perna A, Faughnan ME. Liver involvement in hereditary hemorrhagic [DOI: 10.1053/j.gastro.2006.06.054](https://doi.org/10.1053/j.gastro.2006.06.054). - Garcia-Tsao G. Portal hypertension Current Opinion In Internal Medicine 2006, 5: 399-407. [DOI: 10.1097/01.mog.0000218962.93806.9a](https://doi.org/10.1097/01.mog.0000218962.93806.9a). - GarciaTsao G, D'Amico G, Abraldes J, Schepis F, Merli M, Kim W, Christensen E. Session 2: Predictive Models in Portal Hypertension 2006, 47-102. [DOI: 10.1002/9780470988831.ch4](https://doi.org/10.1002/9780470988831.ch4). - [DOI: 10.1016/b978-1-4160-3258-8.50024-3](https://doi.org/10.1016/b978-1-4160-3258-8.50024-3). [Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders](http://www.ncbi.nlm.nih.gov/pubmed/16611189)Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Sernyak M, Wongcharatrawee S, GarciaTsao G. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders Journal Of Viral Hepatitis 2005, 13: 235-241. [PMID: RL, JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, Barnes DS, Bonacini M, Lindsay KL, Mills AS, Markin RS, Rubin R, AB, AF. Methotrexate (MTX) G. Transjugular 2005, 251-259. [DOI: 10.1002/9780470987476.ch20](https://doi.org/10.1002/9780470987476.ch20). M, Balk R, Christman B, Moreau R, Garcia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis 1963; in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome [Ann Intern Med 1964; 60: 568-580]](https://doi.org/10.1016/s0168-8278(04)00392-7)GARCIATSAO G. Spontaneous bacterial peritonitis: a historical perspectiveKerr DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis 1963; in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome [Ann Intern Med 1964; G. Treatment of acute variceal bleeding: general management and on the consensus conference of the international Ascites club](http://www.ncbi.nlm.nih.gov/pubmed/12830009)Moore K, Wong F, Gines P, Bernardi M, Ochs Salerno F, Angeli M, Moreau R, GarciaTsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: Report on the consensus conference of the Intestinal Flora in Experimental Prehepatic Portal Hypertension](http://www.ncbi.nlm.nih.gov/pubmed/12822876)Wiest R, Chen F, Cadelina G, Groszmann R, Garcia-Tsao G. Effect of Lactobacillus-Fermented Diets on Bacterial Translocation and Intestinal Flora in Experimental Prehepatic Portal Hypertension Digestive And 12822876](https://pubmed.ncbi.nlm.nih.gov/12822876), [DOI: 10.1023/a:1023729115659](https://doi.org/10.1023/a:1023729115659). - GarciaTsao G. Portal In Internal Medicine 2003, 2: 229-237. [DOI: 10.1097/00132980-200302030-00003](https://doi.org/10.1097/00132980-200302030-00003). [Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA)](https://doi.org/10.1016/s0016-5085(03)83945-8)Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Semyak M, Wongcharatrawee S, Garcia-Tsao G. Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA) the prevention of the complications of portal hypertension: final results and identification of a predictive factor](https://doi.org/10.1016/s0270-9139(03)80146-5)Groszmann R, Garcia-Tsao G, Makuch R, Bosch J, Escorsel A, Garcia-Pagan J, Grace N, Matloff D, Burroughs A, Patch D. 103 Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor Hepatology 2003, 38: 206. [DOI: 10.1016/s0270-9139(03)80146-5](https://doi.org/10.1016/s0270-9139(03)80146-5). [553 Histologic-hemodynamic correlations in hepatitis C and other chronic liver diseases \u2014 is there a histologically mild and severe cirrhosis?](https://doi.org/10.1016/s0270-9139(03)80595-5)Nagula S, Jain D, Groszmann R, Garcia-Tsao G. 553 Histologic-hemodynamic correlations in hepatitis C and other chronic liver diseases \u2014 is there a histologically mild and severe analgesics to therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?](http://www.ncbi.nlm.nih.gov/pubmed/11839726)Burroughs A, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pagan J, Dagher L. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better Bosch J, GarciaTsao G, Richardson C, Matloff D, Rod\u00e9s J, Conn H. Propranolol for the prevention of first esophageal variceal CLINICAL MANAGEMENT OF ASCITES AND ITS COMPLICATIONS Clinics In Liver Disease 2001, 5: 833-850. [PMID: 11565143](https://pubmed.ncbi.nlm.nih.gov/11565143), [DOI: 10.1016/s1089-3261(05)70194-x](https://doi.org/10.1016/s1089-3261(05)70194-x). - Garcia-Tsao [PMID: hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis](http://www.ncbi.nlm.nih.gov/pubmed/11179247)Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal Henderson J, Laine L, Nevens F, Riggio O. Session 1 Definition of Key Events: Lets's Try Again 2001, 13-21. [DOI: 10.1002/9780470760154.ch2](https://doi.org/10.1002/9780470760154.ch2). Nevens F, Cestari R, Caletti G, Zoli M. Session 2 Diagnosis of Portal Hypertension: How and When 2001, 36-64. [DOI: 10.1002/9780470760154.ch4](https://doi.org/10.1002/9780470760154.ch4). P, Merli M, Rodes J, Stiegmann G. Session 8 Complications in the Medical Treatment of Portal Hypertension 2001, 180-203. [DOI: 10.1002/9780470760154.ch12](https://doi.org/10.1002/9780470760154.ch12). [Prokinetics reduce bacterial translocation in cirrhosis: Will sweeping the gut keep the fluid clean?](http://www.ncbi.nlm.nih.gov/pubmed/11208746)Garc\u00eda-Tsao G. Prokinetics reduce bacterial translocation in cirrhosis: Will sweeping the gut L, Henderson K, Jain D, Byrd B, Pollak J, White R. Liver Disease in Patients with Hereditary Hemorrhagic Telangiectasia New England Journal Of 11006369](https://pubmed.ncbi.nlm.nih.gov/11006369), [DOI: 10.1056/nejm200009283431305](https://doi.org/10.1056/nejm200009283431305). - [PMID: 17023887](https://pubmed.ncbi.nlm.nih.gov/17023887), [DOI: 10.1097/00001574-200005000-00012](https://doi.org/10.1097/00001574-200005000-00012). [Ultrasound the of clinically significant portal hypertension (CS-PHT) in compensated cirrhosis](https://doi.org/10.1016/s0016-5085(00)86014-x)Ayala J, Zalwin M, Taylor C, Bosch J, Groszmann R, Garcia-Tsao G. Ultrasound parameters in the prediction of clinically significant portal hypertension (CS-PHT) in compensated cirrhosis L, Planas R, Bernard B, Inadomi J, Club T. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document R. Bacterial and Wheeler D, Rubin R, West A, Mills A, Eigenbrodt E, Maddrey W, Munoz S, GarciaTsao G, Bonner G, Boyer J, Luketic V, Shiffman M, Peters M, White H, Zetterman R, Carithers R. The effect of ursodeoxycholic acid therapy of portal hypertension: A caution](http://www.ncbi.nlm.nih.gov/pubmed/10464155)Garc\u00eda-Tsao G. Angiotensin II receptor antagonists in the pharmacological therapy of portal - Identifying new risk factors for spontaneous bacterial peritonitis: How important G, Bonner G, Boyer J, Luketic V, Shiffman M, Peters M, White H, Zetterman R, Risser R, Rossi S, Hofmann A. Biliary bile in pressure measurements](http://www.ncbi.nlm.nih.gov/pubmed/10094948)Steinlauf A, GarciaTsao G, T, Groszmann R. Lowdose midazolam sedation: An option for patients A, Pagliaro L, Makuch R, Bosch J, Stiegmann G, Henderson J, de Franchis R, Wagner J, Conn H, Rodes J. Portal hypertension and variceal bleeding: An of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis](http://www.ncbi.nlm.nih.gov/pubmed/9657091)GarciaTsao G, Angulo P, Garcia J, Groszmann R, Cadelina G. The diagnostic and predictive value of ascites nitric oxide levels in patients with 1998, 14: 256-264. [DOI: 10.1097/00001574-199805000-00012](https://doi.org/10.1097/00001574-199805000-00012). - Garc\u00eda-Tsao G. Further against Garcia-Tsao G, Cartun R, Emanuel J, West A. Viral RNA in duodenal bile of cirrhotic patients with chronic hepatitis C. Archives Of Pathology & Laboratory Medicine 1997, 121: 847-52. [PMID: 9278613](https://pubmed.ncbi.nlm.nih.gov/9278613). [The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices](http://www.ncbi.nlm.nih.gov/pubmed/9178694)Escorsell A, Ferayorni L, Bosch J, Garcia-Pagan J, Garcia-Tsao G, Grace N, Rodes J, Groszmann R. The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than favor portal pressure reduction in the prevention of variceal hemorrhage](http://www.ncbi.nlm.nih.gov/pubmed/9136864)Garc\u00eda-Tsao G. Further evidence in favor of pharmacological portal pressure reduction in the prevention 1997, 13: 263-270. [DOI: 10.1097/00001574-199705000-00013](https://doi.org/10.1097/00001574-199705000-00013). Opinion Gastro 13:263-270, 1997. [Doppler ultrasound in the cirrhotic patients: The prevalence of intrahepatic arteriovenous shunting, and implications for diagnosis of hepatocellular carcinoma](http://www.ncbi.nlm.nih.gov/pubmed/9372563)Taylor C, Garcia-Tsao G, Henson B, Case C, Taylor K. Doppler ultrasound in the evaluation of cirrhotic patients: The prevalence of intrahepatic arteriovenous shunting, and implications for diagnosis of hepatocellular carcinoma Ultrasound In Medicine & Biology 1997, 23: 9372563](https://pubmed.ncbi.nlm.nih.gov/9372563), ofloxacin: Inpatient or outpatient therapy?](http://www.ncbi.nlm.nih.gov/pubmed/8831614)Garc\u00eda-Tsao G. Treatment of spontaneous bacterial peritonitis with oral B, Carithers R, Maddrey W, Lin D, McDonald M, Wheeler D, Eigenbrodt E, Mu\u00f1oz S, Rubin R, Garcia-Tsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A placebo-controlled trial cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/7657280)Combes B, Carithers R, Maddrey W, Lin D, McDonald M, Wheeler D, Eigenbrodt E, Mu\u00f1oz S, Rubin R, GarciaTsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A randomized, cirrhosis](https://doi.org/10.1016/0270-9139(95)90294-5)Combes B, Carithers R, Maddrey W, Lin D, Mcdonald M, Wheeler D, Eigenbrodt E, Mu\u00f1oz S, Rubin R, Garcia-tsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A randomized, Cartun R, West A. Bacterial translocation to mesenteric lymph nodes is increased in 10.1016/0016-5085(95)90147-7](https://doi.org/10.1016/0016-5085(95)90147-7). S, Emanuel J, Howe C, West A, Garcia-Tsao G. Detection of hepatitis C virus RNA by RT-PCR in the bile of patients with hepatitis C Antonica G, Ferraioli G, Jensen J, Lerner E, Antonica G, Ferraioli G, Jensen J, Lerner E, Portal Vein Thrombosis, and Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/7806833)Orozco T, Garcia-Tsao G, Mercado M, Prado E, Nava R. A Comparative Clinical Study of Idiopathic Portal Hypertension, Extrahepatic Portal Vein Thrombosis, and GarciaTsao Bacterial translocation in acute and chronic Garcia-Tsao G. Decreasing Liver Biopsy Annals Of Internal Medicine 1993, 119: 436. [DOI: 10.7326/0003-4819-119-5-199309010-00020](https://doi.org/10.7326/0003-4819-119-5-199309010-00020). - GarciaTsao G, Albillos A, Barden G, West A. Bacterial translocation in acute and chronic hypertension [PMID: 8514258](https://pubmed.ncbi.nlm.nih.gov/8514258), Outpatient liver biopsy: how safe is it? Annals Of Internal Capell\u00e1n^S J, Garcia-Tsao G. Elective treatment of bleeding varices with the Sugiura operation over 10 years The American Journal Of cause of acute anemia in a patient with the acquired immunodeficiency syndrome](http://www.ncbi.nlm.nih.gov/pubmed/1537498)Garcia-Tsao G, Panzini L, Yoselevitz M, West A. Bacillary peliosis hepatis as a cause of acute anemia in a patient with the acquired immunodeficiency syndrome R, [The Sugiura hypertension secondary to extrahepatic portal vein thrombosis.](http://www.ncbi.nlm.nih.gov/pubmed/1866670)Orozco H, Takahashi T, Mercado M, Garcia-Tsao G, Hernandez-Ortiz J. The Sugiura procedure for patients with hemorrhagic portal hypertension secondary to extrahepatic portal vein thrombosis. Journal Of The American College Of Surgeons 1991, 173: 45-8. [PMID: 1866670](https://pubmed.ncbi.nlm.nih.gov/1866670). [Propranolol in the esophagogastric varices: A multicenter, randomized Groszmann R, Rod\u00e9s J, Wright S, Matloff D, GarciaTsao G, Fisher R, Navasa M, Drewniak S, Atterbury C, Bordas J, Lerner E, Bramante C. Propranolol in the prevention of the first hemorrhage from esophagogastric with tense ascites treated with total paracentesis: results of a randomized study Planas R, Gines P, Arroyo V, Llach J, J, V, JM, Dextran-70 plasma-expanders in cirrhotic patients with tense ascites treated with total paracentesis: results of a randomized study Planas R, Gines P, Arroyo V, Llach J, F, Hernandez-Cendejas A. Partial hepatectomy for Caroli's syndrome. Report of two with prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage](http://www.ncbi.nlm.nih.gov/pubmed/2210246)Groszmann R, Bosch J, Grace N, Conn H, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M, Rofe S, Patrick M, Lerner E. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of Gonzalez-Lopez-Lira A, Hernandez-Ortiz J. Postoperative portal vein obstruction in patients with idiopathic portal hypertension. Journal Of Clinical Guevara L, Ort\u00edz J, A, Tielve M. Role of the distal splenorenal shunt in management of variceal bleeding in Latin America The American Journal Of Surgery 1990, 160: 86-89. L, Hernandez-Ortiz J, Tielve M. Selective portal-systemic shunts for bleeding Garc\u00eda-Tsao G, Hern\u00e1ndez-Ortiz J. Surgical treatment of hemorrhage of esophageal varices secondary to thrombosis of the portal microbiologic study of liver biopsy in the diagnosis of fever of unknown origin.](http://www.ncbi.nlm.nih.gov/pubmed/2291060)P\u00e1ez-Rodr\u00edguez O, Garc\u00eda-Tsao G, Sifuentes J. Usefulness of the histologic and microbiologic study of liver biopsy in the diagnosis of fever of unknown origin. Revista Gastroenterolog\u00eda placebocontrolled trial](http://www.ncbi.nlm.nih.gov/pubmed/2511136)Bosch J, Garc\u00edaTsao G, M, A, Rod\u00e9s J. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of Takahashi T. Idiopathic portal hypertension and protein C deficiency to editor 1989, Garcia-Tsao G. Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. Journal Of Clinical R, Gent M, Rojkind M. fibropolycystic disease Mexico. trial](http://www.ncbi.nlm.nih.gov/pubmed/3056820)Grace N, Conn H, Resnick R, Groszmann R, Atterbury C, Wright S, Gusberg R, Vollman R, GarciaTsao G, Fisher R, O'Hara E, McDermott W, Maselli J, Widrich W, Matloff D, Horst D, Banks portalsystemic after R, Anaya R, RuizArguelles G, HernandezOrtiz J, Casillas M, Guevara L. Deficiency of protein C in patients with portal vein thrombosis Tamayo R, Gent M, Rojkind M. Colchicine in the Treatment of Cirrhosis of the Liver New England Journal Of Medicine 1988, 318: 1709-1713. [PMID: 3287167](https://pubmed.ncbi.nlm.nih.gov/3287167), [DOI: 10.1056/nejm198806303182602](https://doi.org/10.1056/nejm198806303182602). - M\u00e9xico S, liver and in patients with diffuse liver disease: importance of fat.](http://www.ncbi.nlm.nih.gov/pubmed/3520657)Taylor K, Riely C, Hammers L, Flax S, Weltin G, Garcia-Tsao G, Conn H, Kuc R, Barwick K. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. R, Conn H, Bermann M, Patrick M, Morse S, Alberts J. Shortterm effects of propranolol Garcia-Tsao E. The diagnosis of bacterial peritonitis Gastroenterology 1985, 89: 694. [DOI: 10.1016/0016-5085(85)90474-3](https://doi.org/10.1016/0016-5085(85)90474-3). - GarciaTsao R, Fisher R, Conn H, Atterbury C, Glickman M. Portal pressure, presence of gastroesophageal 10.1002/hep.1840050313](https://doi.org/10.1002/hep.1840050313). - GarciaTsao G, Conn H, Lerner E. The diagnosis of bacterial peritonitis: Comparison of pH, lactate concentration and 5: 91-96. [PMID: [DOI: 10.1002/hep.1840050119](https://doi.org/10.1002/hep.1840050119). - Guevara L, Garcia Tsao G, Uscanga L. A study with quinfamide in the treatment of chronic amebiasis in adults. Clinical Therapeutics 1983, 6: F, Vargas Laviada E, Mac\u00edas T, Ovalle F, Quibrera R, Rivera-Damm R, Vargas L, Valverde C. Study Group for Thyroid Cancer in Mexico (CATIMEX). Collaborative study of 194 F, Garc\u00eda Tsao G, Rojkind M, Kershenobich D. Early detection of alcoholism in a hospital population Relationship between blood lactic acid and Tsao G, V\u00e1zquez V, de la Rosa C, Guevara L. Collagen synthesis (C.S.) in acute bacterial intoxication after jejunal bypass (J.B.) Street, 1ANew Haven, CT 06510 - VA Connecticut Healthcare SystemVA Connecticut Healthcare950 Campbell Avenue, Wing West Haven CampusWest Haven, CT 06516 Biography Guadalupe Garcia-Tsao, MD, is chief of digestive diseases for the VA-CT Healthcare System and director of the Clinical and Translational Core of the Yale Liver Center. She treats patients with liver disease, and has particular expertise in cirrhosis and portal hypertension. She also manages patients with portal hypertension caused by conditions other than cirrhosis. Dr. Garcia-Tsao has completed many clinical studies that have led to improving the management of patients with complications of cirrhosis and is currently interested in issues regarding the progression (or regression) of cirrhosis. \"Patients with cirrhosis and portal hypertension have inspired my clinical practice and my research,\" says Dr. Garcia-Tsao, a professor of medicine (digestive diseases) at Yale School of Medicine. \"Cirrhosis is the end-stage of any chronic liver disease, and with advances in science, we have different measures to better treat the complications of cirrhosis. We are currently working at measures to prevent these complications from even occurring or to induce cirrhosis regression.\" Titles - Professor of Medicine (Digestive Diseases) Education & Training - Liver Research fellowshipYale University (1985) - GI FellowshipInstituto Nacional de la Nutricion (1982) - Intern/ResidentInstituto Nacional de la Nutricion (1980) - MDUniversidad Nacional Autonoma de Mexico (1977) Languages Spoken - English - Italiano (Italian) - Espa\u00f1ol (Spanish) Additional Information - Jimenez J, Garcia-Tsao G, Saffo S. Emerging concepts in the care of patients with cirrhosis and septic shock World Journal M, Garcia-Tsao G. Update in the Treatment of the Complications of Cirrhosis Clinical for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36972386)Rabiee A, Mahmud N, Falker C, Garcia-Tsao G, Taddei T, Kaplan D. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis](https://doi.org/10.1016/j.jhepr.2023.100727)D\u00edaz L, Fuentes-L\u00f3pez E, Ayares G, Idalsoaga F, Arnold Valverde M, Perez D, G\u00f3mez J, Escarate R, Villal\u00f3n A, Ram\u00edrez C, Hernandez-Tejero M, Zhang W, Qian S, Simonetto D, Ahn J, Buryska S, Dunn W, Mehta H, Agrawal R, Cabezas J, Garc\u00eda-Carrera I, Cuy\u00e0s B, Poca C, Louvet A, Garc\u00eda-Tsao G, Roblero J, Abraldes V, Kamath P, Arrese M, Singal A, Bataller R, Arab J. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis JHEP Reports 2023, 100727. [DOI: 10.1016/j.jhepr.2023.100727](https://doi.org/10.1016/j.jhepr.2023.100727). [O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY](https://doi.org/10.1016/j.aohep.2023.101035)Idalsoaga F, D\u00edaz L, Ayares G, Arnold J, Dunn W, Li Y, Singal A, Simonetto D, Ayala-Valverde M, Perez D, Gomez J, Escarate R, Fuentes-L\u00f3pez E, Ramirez C, Morales-Arraez D, Zhang W, Qian S, Ahn J, Buryska S, Mehta H, Waleed M, Stefanescu H, Horhat A, Bumbu A, Attar B, Poca M, Pastor G, Sarin S, Maiwall R, Jalal P, La Tijera M, Kulkarni A, P N, Salazar P, Skladan\u00fd V, Clemente-Sanchez P, Mendizabal S, Dirchwolf M, Vargas V, Jimenez C, Garc\u00eda-Tsao G, Ortiz G, Abraldes J, Kamath P, Arrese M, Shah V, Bataller R, Arab J. O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY 101035. [DOI: 10.1016/j.aohep.2023.101035](https://doi.org/10.1016/j.aohep.2023.101035). - Nadim M, Garcia-Tsao G. Acute Kidney Injury in Patients with Cirrhosis New England Journal Of Medicine 2023, hypertension assessments in nonalcoholic steatohepatitis cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36647687)Noureddin M, Goodman Z, Tai D, Chng E, Ren Y, Boudes P, Shlevin H, GarciaTsao G, Harrison S, Chalasani N. Machine learning liver histology scores correlate with portal assessments Cirrhosis Complicated by Portal Hypertension](http://www.ncbi.nlm.nih.gov/pubmed/36516940)Ferral H, Schepis F, Gaba Z, Garcia-Pagan J. Endovascular Assessment of Liver Hemodynamics in Patients with Cirrhosis Complicated by Portal Hypertension Journal Signature in Patients with Alcohol-Associated Cirrhosis](https://doi.org/10.1182/blood-2022-162633)Allen C, Butt A, Zhao X, Li F, Bahel P, Chang C, Chun H, Gu S, Hwa J, Jakab S, Chen B, Garcia-Tsao G, Rinder H, To U, McConnell M, Lee A, Pine A. Plasma Proteomic Profiling Illustrates Endothelial and Complement Signature in Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36328307)Bajaj J, Lai J, Tandon P, O'Leary J, Wong F, Garcia-Tsao G, Vargas H, Kamath P, Biggins S, Limon-Miro A, Shaw J, Mbachi C, Chew M, Golob Deeb J, Thacker L, Reddy K. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH\": Comment parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH\": Comment from Hartmann et 10.1007/978-3-031-08552-9_47](https://doi.org/10.1007/978-3-031-08552-9_47). - T, C, D'Amico G, La Mura V, Piano S, Tandon P, Turco L. Preventing Further Decompensation: Consensus 7 2022, 579-583. [DOI: 10.1007/978-3-031-08552-9_51](https://doi.org/10.1007/978-3-031-08552-9_51). [Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a labbased model](http://www.ncbi.nlm.nih.gov/pubmed/36214066)Rabiee A, Deng Y, Ciarleglio M, Chan JL, Pons M, Genesca J, GarciaTsao G. Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of A Meta-analysis Based on Randomized J, Pivalizza E, Garcia-Tsao G. Thromboelastography-Guided Therapy Enhances Patient Blood Management in Cirrhotic Patients: A Meta-analysis Based on Randomized at hospital admission with nosocomial development in patients cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/36017804)Bajaj P, GarciaTsao G, Kamath Wong F, Lai J, Vargas H, Thuluvath PJ, Subramanian RM, PenaRodriguez M, of metabolites and gut microbiota at hospital admission with nosocomial infection development in patients histologic scores correlating with portal pressures and the development of varices in NASH patients with cirrhosis](https://doi.org/10.1016/s0168-8278(22)01564-1)Noureddin M, Tai D, Chng E, Ren Y, Boudes P, Shlevin H, Harrison S, Garcia-Tsao G, Goodman Z, Chalasani N. FRI516 Derivation of machine learning histologic scores correlating with portal pressures and the development of varices in NASH patients with automated detection of septa and nodules in needle liver biopsies of NASH cirrhosis](https://doi.org/10.1016/s0168-8278(22)01557-4)Noureddin M, Tai D, Chng E, Ren Y, Boudes P, Shlevin H, Harrison S, Garcia-Tsao G, Chalasani N, Goodman Z. FRI509 Use of second-harmonic generation microscopy for automated detection of septa and nodules in needle liver biopsies of at admission have comparable outcomes in a multi-center cohort of inpatients with cirrhosis](https://doi.org/10.1016/s0168-8278(22)02066-9)O'Leary J, Reddy K, Tandon P, Kamath P, Garcia-Tsao G, Wong F, Lai J, Subramanian R, Thuluvath P, Maliakkal B, Vargas H, L, Bajaj J. SAT496 SBP vs. non-SBP bacterial infections at admission have comparable outcomes in a multi-center cohort of inpatients of nosocomial infections in inpatients with cirrhosis](https://doi.org/10.1016/s0168-8278(22)01041-8)Bajaj J, O'Leary Garcia-Tsao P, Subramanian R, Vargas H, McGeorge S, Fagan A, Wong F, Lai J, Thacker L, Reddy R. THU494 Serum metabolites on admission associate with the development of nosocomial infections in inpatients Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites](https://doi.org/10.1155/2022/5065478)Bajaj J, Fischer J, Yeramian P, Gavis Fagan A, Angeli P, Garcia-Tsao G, Adams J, Markham P. Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous nonselective betablockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites](http://www.ncbi.nlm.nih.gov/pubmed/35899241)Turco L, Garc\u00edaTsao G. Portal pressure reductions induced by nonselective betablockers improve outcomes and decrease mortality in patients with cirrhosis with and without ascites decompensated cirrhosis: an autopsy study](http://www.ncbi.nlm.nih.gov/pubmed/36160304)Saffo S, Jain D, Sanchez H, Garcia-Tsao G. Invasive fungal infections are underdiagnosed in hospitalized patients with decompensated cirrhosis: OCCURRENCE OF NOSOCOMIAL INFECTIONS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(22)62677-5)Bajaj J, O'Leary J, Tandon P, Garcia-Tsao G, Kamath P, Thuluvath P, Subramanian R, Lai J, Vargas H, Mcgeorge S, Fagan A, Wong F, Thacker L, Reddy K. 82: SERUM METABOLITES ON ADMISSION ASSOCIATE WITH OCCURRENCE OF NOSOCOMIAL AT ADMISSION HAVE COMPARABLE OUTCOMES IN A MULTI-CENTER COHORT OF INPATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(22)63501-7)O'Leary J, Reddy K, Tandon P, Kamath P, Garcia-Tsao G, Wong F, Lai J, Subramanian R, Thuluvath P, Maliakkal B, Vargas H, L, Bajaj J. Sa1456: SBP VERSUS NON-SBP BACTERIAL INFECTIONS AT ADMISSION HAVE COMPARABLE OUTCOMES IN A MULTI-CENTER COHORT to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated A Global Study](http://www.ncbi.nlm.nih.gov/pubmed/35501978)Morales-Arr\u00e1ez Altamirano J, Cruz-Lemini M, Thursz M, Atkinson S, Sarin S, Kim W, Chavez-Araujo R, la Tijera M, Singal A, Shah V, Kamath P, Duarte-Rojo A, Charles E, Vargas V, Jager M, Rautou P, Rincon D, Zamarripa F, Restrepo-Guti\u00e9rrez P, Louvet A, Garc\u00eda-Tsao G, Gonz\u00e1lez J, Verna R, Argemi J, Fern\u00e1ndez-Carrillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. Correction to: The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study OF 3-MONTH HOSPITALIZATION IN A MULTI-CENTER CIRRHOSIS COHORT](https://doi.org/10.1016/s0016-5085(22)60136-7)Bajaj J, Lai J, Tandon P, O'Leary J, Garcia-Tsao G, Wong F, Vargas H, Kamath P, Biggins S, Shaw J, Limon-Miro A, Chew M, Mbachi C, Thacker L, Reddy R. 256: PRIOR PERIODONITIS AND PATIENT-REPORTED OUTCOMES PREDICT THE RISK OF Kamath PS, Tandon JS. Prognosis of hospitalized patients with cirrhosis and acute Liver Hag M, Abraldes JG, Alvarado E, Clemente Ravi S, Alves A, Alboraie M, Altamirano R, Caballeria J, Cabezas J, Carvalhana S, Cortez-Pinto H, Costa MR, Masson S, Mathurin P, Mendez-Sanchez N, Miquel R, Moreno C, Mounajjed T, Odena G, Kim W, Sancho-Bru P, Sands R, Szafranska J, Verset L, Schnabl B, Sempoux C, Shah RE, Straub BK, Verna E, Tiniakos JT, M, Mueller S, St\u00e4rkel P, Bataller R. Clinical, histological and molecular profiling of different stages of alcohol-related Gut Ripoll J, Ba\u00f1ares M, Benajiba L, Berzigotti A, Bureau C, Calvaruso V, Cardenas A, D'Amico G, De Gottardi A, Dell'Era A, Escorsell A, Fallowfield J, Rodrigues S, Gracia-Sancho J, Han G, Hernandez-Gea V, Jia J, Kiladjian J, Krag A, Laleman W, La Mura V, Lens S, Luo X, Mandorfer M, Murad S, Paradis V, Patch D, Piano S, Pinzani M, Plessier A, Primignani M, Procopet D, Villanueva C, Wanless I, Yoshiji H. Baveno VII - Renewing consensus in the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated A Global Study](http://www.ncbi.nlm.nih.gov/pubmed/34962498)Morales-Arr\u00e1ez Altamirano J, Cruz-Lemini M, Thursz M, Atkinson S, Sarin S, Kim W, Chavez-Araujo R, la Tijera M, Singal A, Shah V, Kamath P, Duarte-Rojo A, Charles E, Vargas V, Jager M, Rautou P, Rincon D, Zamarripa F, Restrepo-Guti\u00e9rrez P, Louvet A, Garc\u00eda-Tsao G, Gonz\u00e1lez J, Verna R, Argemi J, Fern\u00e1ndez-Carillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant Clinical AND AFTER HCV CURE AND CORRELATION WITH CLINICAL OUTCOMES](https://doi.org/10.1016/j.aohep.2021.100493)Ragazzo T, Garcia-Tsao G, Mazo D, Ziteli P, Oliveira C, Singer J, F, Pessoa M. O-6 NON-INVASIVE ASSESSMENT OS HEPATIC FIBROSIS BEFORE AND AFTER HCV CURE AND CORRELATION WITH Annals Of Hepatology 2021, 24: 100493. [DOI: Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases](http://www.ncbi.nlm.nih.gov/pubmed/33942342)Biggins SW, Angeli P, GarciaTsao G, Gin\u00e8s P, Ling SC, Nadim MK, Wong F, Kim WR. Diagnosis, Evaluation, and of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With AlcoholAssociated Hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/34109723)Musto JA, Eickhoff J, VenturaCots M, Abraldes JG, BosquesPadilla Verna EC, Brown RS, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross D, Louvet G, Schnabl B, Bataller R, Lucey MR. The Level of Alcohol Consumption in the Prior Year Does Not Impact Clinical Outcomes in Patients With AlcoholAssociated Hepatitis Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/34002868)Bajaj JS, GarciaTsao G, Reddy KR, O'Leary P, Subramanian RM, Thuluvath P, Fagan A, T, LR, Wong F. Admission Urinary and Serum Metabolites Predict A, Parmer C, Yang H, Jain D, Lim B, Goodman AL, GarciaTsao G. Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With G, P. Determinants of increased thrombotic tendency in Liver Injury Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death](http://www.ncbi.nlm.nih.gov/pubmed/34004326)Chew M, Tang Z, Radcliffe C, Caruana D, Doilicho N, Ciarleglio MM, Deng Y, Garcia-Tsao G. Significant Liver Injury During Hospitalization for COVID-19 Is Not Associated With Liver Insufficiency or Death ON ADMISSION PREDICT THE DEVELOPMENT OF AKI AND NEED FOR DIALYSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(21)02565-8)Bajaj J, Garcia-Tsao G, Reddy R, O'Leary J, Vargas H, Lai J, Kamath P, Tandon P, Subramanian R, Thuluvath P, Fagan A, Sehrawat T, De La R, Wong F. 431 SPECIFIC URINARY AND SERUM METABOLITES ON ADMISSION PREDICT THE DEVELOPMENT OF AKI AND NEED FOR DIALYSIS IN HOSPITALIZED PATIENTS WITH CIRRHOSIS Gastroenterology 2021, 160: in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation](http://www.ncbi.nlm.nih.gov/pubmed/33771685)Kaplan D, Mehta Garcia-Tsao G, Albrecht J, Aytaman A, Baffy G, Bajaj J, Hernaez R, Hunt K, Ioannou G, Johnson K, Kanwal F, Lee T, Monto A, Pandya P, Schaubel T. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events Mortality and Readmissions Over 90 Days Regardless of COVID19: A Multicenter Cohort](http://www.ncbi.nlm.nih.gov/pubmed/33427401)Bajaj GarciaTsao G, Wong F, Biggins SW, Kamath PS, McGeorge S, Chew M, Pearson M, Shaw J, Kalluri A, Fagan A, Olofson A, Moini M, de la Rosa Rodriguez R, Reddy KR. Cirrhosis Is Associated With High Mortality and Readmissions Over 90 Days Regardless of COVID19: A Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/33681681)Balakrishnan M, Falker C, Conley S, Ciarleglio M, Deng Y, Redeker NS, GarciaTsao G. Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases](http://www.ncbi.nlm.nih.gov/pubmed/33219529)Northup PG, GarciaPagan J, GarciaTsao DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Indicator of ProcedureRelated Bleeding in Decompensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/33553974)Zanetto A, Rinder HM, Senzolo M, Simioni P, GarciaTsao G. Reduced Clot Stability by Thromboelastography as a Potential Indicator of ProcedureRelated Bleeding in cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension](http://www.ncbi.nlm.nih.gov/pubmed/33210815)Saffo S, GarciaTsao G, Taddei T. SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension Journal Of Diabetes 2020, 13: Ascites Peripheral and PostPandemic Era: Challenges and the Need for Innovation](http://www.ncbi.nlm.nih.gov/pubmed/32740969)Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, GarciaTsao G, Terrault N, Lok AS, Chung RT, Reddy KR. Clinical Research in Hepatology in the COVID19 Pandemic and PostPandemic Era: Challenges and in patients with cirrhosis: a systematic review](http://www.ncbi.nlm.nih.gov/pubmed/32998172)Rabiee A, Ximenes R, Nikayin S, Hickner A, Juthani P, Rosen RH, GarciaTsao G. Factors associated with healthrelated quality of life in patients with cirrhosis: a systematic review Liver Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations Journal Of and Hypercoagulable Features](http://www.ncbi.nlm.nih.gov/pubmed/32614088)Zanetto Rinder HM, Campello M, Gavasso S, Bulato C, P, GarciaTsao G. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Jiang Lang S, Duan Y, Zhang X, Gao B, Chopyk J, Schwanemann LK, VenturaCots M, Bataller R, BosquesPadilla Brown RS, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross DL, Ho XM, P, Pride D, Fouts DE, Schnabl B. Intestinal Virome in Patients is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis](https://doi.org/10.1016/s0168-8278(20)30921-1)Zanetto A, Rinder H, Deng Y, Ciarleglio M, Wilson F, Bulato C, Simioni P, Garcia-Tsao G. THU137 Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated 1b acute kidney injury in cirrhosis is likely due to underlying chronic kidney disease and would be more appropriately re-classified as acute-on-chronic kidney disease](https://doi.org/10.1016/s0168-8278(20)30623-1)Wong F, Reddy S, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas H, Subramanian R, Thuluvath P, Kamath P, Thacker L, Bajaj J. AS044 Stage 1b acute kidney injury in cirrhosis is likely due to underlying chronic kidney disease and would be more appropriately re-classified as acute-on-chronic kidney disease Journal delivered by continuous intravenous infusion in patients with cirrhosis refractory Fagan A, Fischer J, Garcia-Tsao G, Angeli P, Smith D, Adams J, Markham P. SAT139 Safety, tolerability, pharmacokinetics and pharmacodynamic activity of terlipressin delivered by continuous intravenous infusion in patients with cirrhosis and refractory ascites: a [Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/32687928)Bajaj JS, Reddy KR, O'Leary JG, Vargas HE, Lai Tandon P, Wong F, Subramanian RM, Thuluvath P, Fagan A, White MB, Gavis EA, T, la Rodriguez M, Garcia-Tsao G, Gillevet PM. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/31837238)D'Amico G, Abraldes JG, Rebora P, Valsecchi MG, GarciaTsao G. Ordinal Outcomes Are Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis An Emerging Tool for Liver Education and IS ASSOCIATED WITH REVERSIBLE PLATELET DYSFUNCTION IN HOSPITALIZED PATIENTS WITH DECOMPENSATED CIRRHOSIS.](https://doi.org/10.1016/s0016-5085(20)33914-7)Zanetto A, Rinder H, Deng Y, Ciarleglio M, Wilson F, Bulato C, Simioni P, Garcia-Tsao G. 1002 ACUTE KIDNEY INJURY IS ASSOCIATED WITH REVERSIBLE PLATELET DYSFUNCTION IN HOSPITALIZED PATIENTS s-1301. [DOI: DEMONSTRATE BETTER PREDICTION FOR 90-DAY READMISSION AND DEATH IN WOMEN THAN MEN WITH CIRRHOSIS.](https://doi.org/10.1016/s0016-5085(20)33859-2)Saboo K, Hu C, Reddy K, O'Leary J, Tandon P, Wong F, Garcia-Tsao G, Kamath P, Lai J, Biggins S, Fallon M, Thuluvath P, Subramanian R, Maliakkal B, Vargas H, Thacker L, Iyer R, Bajaj J. 458 ARTIFICIAL INTELLIGENCE TECHNIQUES DEMONSTRATE BETTER PREDICTION FOR 90-DAY READMISSION AND DEATH IN WOMEN THAN 158: s-1279. [DOI: 10.1016/s0016-5085(20)33859-2](https://doi.org/10.1016/s0016-5085(20)33859-2). IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN PATIENTS WITH COMPENSATED CIRRHOSIS.](https://doi.org/10.1016/s0016-5085(20)34131-7)Ortiz G, Palumbo C, Sayyar M, Balakrishnan M, Mohanty A, Garcia-Tsao G. Su1696 SPLEEN STIFFNESS MEASUREMENTS (SSM) IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN 158: s-1385. [DOI: 10.1016/s0016-5085(20)34131-7](https://doi.org/10.1016/s0016-5085(20)34131-7). [Su1678 IMPACT OF RACE AND ETHNICITY ON OUTCOMES IN A MULTI-CENTER NORTH AMERICAN COHORT OF INPATIENTS WITH CIRRHOSIS](https://doi.org/10.1016/s0016-5085(20)32229-0)Bajaj J, O'Leary J, Tandon P, Wong F, Garcia-Tsao G, Kamath P, Lai J, Biggins S, Fallon M, Maliakkal B, Subramanian R, Thuluvath P, Vargas H, Thacker L, Reddy K. Su1678 IMPACT OF RACE AND ETHNICITY ON OUTCOMES IN A MULTI-CENTER NORTH AMERICAN COHORT OF Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum](http://www.ncbi.nlm.nih.gov/pubmed/32353369)Noureddin M, Chan J, Barradas K, Dimick-Santos L, Schabel E, Omokaro S, Anania F, Myers R, Miller V, Sanyal A, Chalasani N, Group L, Anania F, Bajaj J, Brower A, Calboli D, Chalasani N, Chan J, Charlton W, Dickinson K, Dimick-Santos L, Filozof C, Forsgren M, Fuchs G, Gonzalez-Abraldes J, Gruss H, Hansen M, Hosman S, Imperial J, Jones D, Lalazar G, Leinhard O, Lyons E, McColgan B, Mehta R, Mesenbrink P, Miller V, Myers R, Noureddin M, Omokaro S, Pei V, Ratziu V, Regev A, Riccio R, Sanyal A, Schabel E, Seo S, A, Szitanyi P, Traber P. Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From is reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis](https://doi.org/10.1016/j.dld.2019.12.031)Zanetto A, Rinder H, Deng Y, Ciarleglio M, Wilson F, Bulato C, Simioni P, Garcia-Tsao G. Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis Disease 2020, 52: to Letter 'Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient'](http://www.ncbi.nlm.nih.gov/pubmed/31749290)Ortiz GA, Sayyar M, GarciaTsao G. Author response to Letter to the Editor: 'Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous GarciaTsao G. Prophylactic Antibiotics in Cirrhosis: Are They Promoting or Preventing Infections? after viral elimination in chronic HCV, independent of the presence or absence of cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/31365178)Sayyar M, Saidi M, Zapatka S, Deng Y, Ciarleglio M, GarciaTsao G. Platelet count increases after viral elimination in chronic HCV, independent of the presence or absence of cirrhosis Response to Fungi in Patients With Alcoholic Hepatitis](http://www.ncbi.nlm.nih.gov/pubmed/31228214)Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, VenturaCots M, Abraldes JG, BosquesPadilla F, Verna EC, Brown RS, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross D, Lucey MR, DE, Schnabl B. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis Kamath PS, Bajaj JS, for the Study of the Liver F. Reply Transplantation 2019, 25: Patients with Hepatic Encephalopathy in a Large Multi-Center Cohort](https://doi.org/10.1016/s0016-5085(19)38297-6)Bajaj J, Tandon Wong F, Garcia-Tsao G, Biggins S, Kamath P, Thuluvath P, Lai J, Vargas H, Subramanian R, Maliakkal B, Fallon M, Thacker L, Reddy K. Su1527 - Potentially Preventable Readmissions and Complications in Hospitalized Patients with Hepatic Encephalopathy Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients with Alcoholic Hepatitis](https://doi.org/10.1016/s0016-5085(19)39939-1)Lang S, Duan Y, Liu J, Ventura-Cots M, Lucey M, Padilla F, Mathurin P, Louvet A, Garcia-Tsao G, Verna E, Abraldes J, Brown R, Vargas V, Altamirano J, Caballer\u00eda J, Shawcross D, Ho S, Bataller R, Tu X, St\u00e4rkel P, Fouts D, Schnabl B. 246 - Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients with Alcoholic Hepatitis Gastroenterology 2019, 156: s-1186. [DOI: 10.1016/s0016-5085(19)39939-1](https://doi.org/10.1016/s0016-5085(19)39939-1). [573 - Predictive Factors for the Development of Acute-Onchronic Liver Failure in a North American Cohort of Hospitalized Cirrhotic Patients with Decompensation](https://doi.org/10.1016/s0016-5085(19)39995-0)Wong F, Reddy K, Tandon P, O'Leary J, Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian P, Thacker L, Bajaj J. 573 - Predictive Factors for the Development of Acute-Onchronic Liver Failure in a North American Cohort of Hospitalized Cirrhotic Patients with Decompensation Wong F, Kamath P, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas H, Thuluvath P, Subramanian R, Thacker - The Natural Histyory of Stages 2 & 3 Acute Kidney Injury (AKI) in Patients with Decompensated Cirrhosis and Ascites](https://doi.org/10.1016/s0016-5085(19)40399-5)Wong F, Reddy K, Tandon P, O'Leary Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian L, Bajaj J. Tu1519 - The Natural Histyory of Stages 2 & 3 Acute Kidney Injury (AKI) in Patients with Decompensated of care hepatic encephalopathy: data from a multicentre cohort](http://www.ncbi.nlm.nih.gov/pubmed/31032966)Bajaj Wong SW, GarciaTsao G, Lai J, Fallon MB, B, Subramanian RM, Thacker LR, Reddy KR. Targets to improve quality of care for patients with hepatic encephalopathy: data from a SW, GarciaTsao PJ, Kamath PS, Thacker L, Bajaj JS. Impact of Chronic Kidney Disease on Outcomes in Liver Transplantation 2019, Wong F, Garcia-Tsao G, Kamath P, Maliakkal B, Lai J, Fallon M, Thuluvath P, Subramanian R, Vargas H, Thacker of hospice in inpatients in a large multi-center cohort](https://doi.org/10.1016/s0618-8278(19)31256-3)Bajaj J, Tandon Wong F, Garcia-Tsao G, Biggins S, Kamath P, Thuluvath P, Lai J, Vargas H, Subramanian R, M, Thacker L, Reddy R. and complications in hospitalized patients with hepatic encephalopathy in a large multi-center 70: e630-e631. [DOI: 10.1016/s0618-8278(19)31256-3](https://doi.org/10.1016/s0618-8278(19)31256-3). [SAT-140-The natural history of stages 2 and 3 acute kidney injury in hospitalized patients with decompensated cirrhosis and ascites](https://doi.org/10.1016/s0618-8278(19)31379-9)Wong F, Reddy R, Tandon P, O'leary Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian P, Thacker L, Bajaj J. SAT-140-The natural history of stages 2 and 3 acute kidney injury in hospitalized patients with decompensated cirrhosis and [SAT-139-Predictive factors for the development of acute-on-chronic liver failure in a North American cohort of hospitalized patients with cirrhosis and decompensation](https://doi.org/10.1016/s0618-8278(19)31378-7)Wong F, Reddy R, Tandon P, O'leary J, Garcia-Tsao G, Lai J, Vargas H, Biggins S, Maliakkal B, Fallon M, Subramanian P, Thacker L, Bajaj J. SAT-139-Predictive factors for the development of acute-on-chronic liver failure in a North American cohort of hospitalized patients with cirrhosis and decompensation cirrhosis and severe portal hypertension](https://doi.org/10.1016/s0618-8278(19)30225-7)Garcia-Tsao G, Bosch J, Kayali Z, Harrison S, Abdelmalek M, Lawitz E, Satapathy S, Ghabril M, Shiffman M, Younes Z, Thuluvath P, Berzigotti A, Albillos A, Robinson J, A. LBO-01-Multicenter, double-blind, placebo-controlled, randomized trial of emricasan in subjects with NASH cirrhosis and severe portal hypertension Journal Of Hepatology 2019, 70: e127. [DOI: 10.1016/s0618-8278(19)30225-7](https://doi.org/10.1016/s0618-8278(19)30225-7). [Outcomes After Listing for Transplant in Patients With AcuteonChronic Liver Failure: The Multicenter North American Consortium for the Study of EndStage Liver Disease Experience](http://www.ncbi.nlm.nih.gov/pubmed/30724010)O'Leary J, Bajaj JS, Tandon Wong PS, GarciaTsao G, Maliakkal B, Lai J, Fallon HE, Thuluvath P, Subramanian R, Thacker LR, Reddy K. Outcomes After Listing for Liver Transplant in Patients With AcuteonChronic Liver Failure: The Multicenter North American Consortium for the Study of EndStage Liver Disease Experience Liver Transplantation 2019, Font C, del Carmen D\u00edaz-Pedroche M, Mazzolai L, Little D, Tufano A, Siegal D, Lip G, Monreal M. VENOUS THROMBOEMBOLISM IN PATIENTS WITH LIVER CIRRHOSIS: FINDINGS FROM THE RIETE REGISTRY Journal Of The American College Of Cardiology 2019, 2043. [DOI: 10.1016/s0735-1097(19)32649-x](https://doi.org/10.1016/s0735-1097(19)32649-x). Rockey DC, Shah VH, Bosch J, GarciaTsao G. Prioritization of Therapeutic Targets and Trial Design in GarciaTsao G. AcuteonChronic Liver Failure: An Old Entity in Search of Clarity With Compensated Cirrhosis and Severe Portal Hypertension](http://www.ncbi.nlm.nih.gov/pubmed/30063802)GarciaTsao G, Fuchs Hagerty DT, Bosch J. Emricasan (IDN6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Patients With Advanced Cirrhosis and Portal Vein Thrombosis Should Receive Anticoagulation \"Postparacentesis hemoperitoneum time to become more careful!\"](http://www.ncbi.nlm.nih.gov/pubmed/30145847)Hung A, GarciaTsao G. Author response to Letter to the Editor \"Postparacentesis hemoperitoneum time to become more Platelet Count Increases Viral in Chronic HCV, Independent of Fibrosis Stage](https://doi.org/10.1016/s0016-5085(18)34092-7)Sayyar M, Saidi M, Zapatka Y, Ciarleglio M, Garcia-Tsao G. Tu1542 - Platelet Count Increases after Viral Suppression in Chronic HCV, Independent Fibrosis Stage Gastroenterology 2018, 154: s-1245-s-1246. [DOI: [Tu1543 - of Repeat Liver Stiffness Measurements (LSM) by Transient Elastography (TE) and LSM by Acoustic Radiation Force Impulse (ARFI) in the Clinical Evaluation of Cirrhosis in Patients in whom Initial TE is Equivocal](https://doi.org/10.1016/s0016-5085(18)34093-9)Sayyar M, de Oliveira A, Jangouk P, Bernardo A, Garcia-Tsao G. Tu1543 - Usefulness of Repeat Liver Stiffness Measurements (LSM) by Transient Elastography (TE) and LSM by Acoustic Radiation Force Impulse (ARFI) in the Clinical Evaluation of Cirrhosis in Patients in whom Initial TE is Equivocal Gastroenterology 154: s-1246. [DOI: 10.1016/s0016-5085(18)34093-9](https://doi.org/10.1016/s0016-5085(18)34093-9). [499 - Primary SBP Prophylaxis is Associated with Higher ICU Admission and 30-Day Mortality Compared to Secondary SBP Prophylaxis](https://doi.org/10.1016/s0016-5085(18)33633-3)Bajaj J, O'Leary J, Tandon P, Kamath P, Wong F, Garcia-Tsao G, Lai J, Thuluvath P, Subramanian R, Vargas H, Fallon M, Thacker L, Reddy K. 499 - Primary SBP Prophylaxis is Associated with Higher ICU Admission and 30-Day Mortality Compared to Secondary SBP Prophylaxis Gastroenterology Acid Reduces Bacterial Translocation to Extra-Intestinal Sites and has a Beneficial Intrahepatic Effect](https://doi.org/10.1016/s0016-5085(18)33897-6)Hung A, Yan K, Yang H, Jain D, Garcia-Tsao G. Su1556 - In Experimental Cirrhosis with Ascites, Obeticholic Acid Reduces Bacterial Translocation to Extra-Intestinal Sites and patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/29315693)O'Leary JG, Reddy KR, GarciaTsao G, Biggins Kamath PS, Thuluvath P, Vargas failure prophylaxis is associated with greater ICU admission and 30-day mortality compared to secondary spontaneous bacterial peritonitis prophylaxis](https://doi.org/10.1016/s0168-8278(18)30353-2)Bajaj J, Tandon P, O'leary J, Wong G, Kamath P, Maliakkal B, Fallon M, Thuluvath P, Lai J, Subramanian R, Vargas H, Thacker L, Reddy R. GS-015 Primary spontaneous bacterial peritonitis prophylaxis is associated with greater ICU admission and 30-day mortality compared to secondary spontaneous bacterial peritonitis prophylaxis 13C-methacetin breath test is a highly accurate non-invasive point of care test for detecting CSPH in patients with NASH](https://doi.org/10.1016/s0168-8278(18)30446-x)Bosch J, Bureau C, Chalasani N, Lawitz E, Abdelmalek M, Rinella M, Harrison S, Berzigotti A, Sanyal A, Noureddin M, Rockey D, Ber T, Ilan Y, Garcia-Tsao G. LBP-019 13C-methacetin breath test is a highly accurate non-invasive point of care test for detecting CSPH in patients with NASH Journal Of NASH cirrhosis and portal hypertension](https://doi.org/10.1016/s0168-8278(18)30420-3)Chalasani N, Garcia-Tsao G, Goodman Z, Lawitz E, Abdelmalek M, Rinella M, Ryan M, Noureddin M, Jue C, Pyko M, Allgood A, Shlevin E, Traber P, Loomba R, in with NASH cirrhosis and Of Hepatology 2018, 68: 10.1016/s0168-8278(18)30420-3](https://doi.org/10.1016/s0168-8278(18)30420-3). - [DOI: 10.1007/978-3-319-72628-1_1](https://doi.org/10.1007/978-3-319-72628-1_1). [THREE TYPES OF INTRAHEPATIC SHUNTS PRESENTING PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA](https://doi.org/10.1016/s0735-1097(18)32934-6)Brandt E, Haghighat L, Garcia-Tsao G, Henderson K, Pollak J, Proctor D, Young L. THREE TYPES OF INTRAHEPATIC SHUNTS PRESENTING IN A SINGLE PATIENT WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA Journal Of The American College Of Cardiology 2018, 71: a2393. [DOI: 10.1016/s0735-1097(18)32934-6](https://doi.org/10.1016/s0735-1097(18)32934-6). [Acute kidney injury, but not sepsis, is associated with higher procedurerelated bleeding in patients with decompensated cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/29393567)Hung A, GarciaTsao G. Acute kidney injury, but not sepsis, is associated with higher procedurerelated bleeding in patients with decompensated the New Hepatitis C Antiviral Medications: 'A New Lease on Life'](https://doi.org/10.46743/2160-3715/2018.2740)Giordano N, Brinn A, Garcia-Tsao G, Martino S. Patient Perspectives on Adherence to the New Hepatitis C Antiviral Medications: 'A New Lease on Life' The Qualitative Report 2018 [DOI: 10.46743/2160-3715/2018.2740](https://doi.org/10.46743/2160-3715/2018.2740). - 10.1016/b978-0-323-37591-7.00015-x](https://doi.org/10.1016/b978-0-323-37591-7.00015-x). in hospitalised patients with mortality and factors determining discontinuation and reinitiation](http://www.ncbi.nlm.nih.gov/pubmed/28994122)Bhutta A, GarciaTsao G, Reddy K, Tandon P, Wong F, O'Leary J, Acharya C, Banerjee D, Abraldes J, Jones T, Shaw J, Deng Y, Ciarleglio M, Bajaj J. Betablockers in hospitalised patients with cirrhosis and ascites: mortality and recurrent variceal hemorrhage: Results of an individual patient metaanalysis](http://www.ncbi.nlm.nih.gov/pubmed/28543862)Albillos A, Zamora J, Mart\u00ednez J, Arroyo D, Ahmad I, DelaPe\u00f1a J, GarciaPag\u00e1n J, Lo G, Sarin S, Sharma B, Abraldes JG, Bosch J, GarciaTsao G, Cooperation O. Stratifying risk in the prevention of recurrent variceal hemorrhage: Results B, Tandon P, Vargas H, Thacker L, Bajaj J. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes Deng Y, Garcia-Tsao G. Reply to Risk Stratification in Acute Variceal Bleeding Nacseld Cirrhotic Patients](https://doi.org/10.1016/s0016-5085(17)33569-2)O'Leary J, Reddy K, Tandon P, Kamath P, Wong Garcia-Tsao G, Lai J, Biggins S, Fallon M, Subramanian Nacseld Liver Tandon P, Biggins S, Kamath P, Lai J, Subramanian R, Fallon M, Maliakkal B, H, Thuluvath P, Thacker L, Reddy K. Tu1549 Albumin Use and Acute Kidney Injury in and secondary prophylaxis of esophageal variceal bleeding highrisk varices in patients with compensated cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/28160373)Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, GarciaTsao G. Validating, deconstructing and refining Baveno criteria for ruling out highrisk varices in patients fibrosis and cirrhosis, early decline of liver stiffness following antiviral therapy with DAAs is related to decline in liver inflammation](https://doi.org/10.1016/s0168-8278(17)30876-0)Winters A, Luedtke S, Moreland A, Jangouk P, Weng G, Silveira M, Davitkov P, Duarte-Rojo A, Cheung R, Garcia-Tsao G, Falck-Ytter Y, Branch A, Br\u00e4u N. THU-209 In hepatitis C virus-related advanced fibrosis and cirrhosis, early decline of liver stiffness following antiviral therapy with DAAs is related to decline in liver inflammation Journal Of Hepatology 2017, 66: venous pressure gradient (HVPG) prevents clinical outcomes in compensated and decompensated cirrhosis: a meta-analysis](https://doi.org/10.1016/s0168-8278(17)30468-3)Turco L, Villanueva C, La Mura J, Reiberger T, Genesca J, Groszmann R, Sharma B, Merkel C, Bureau C, Alvarado E, Abraldes J, Albillos A, Banares R, Peck-Radosavljevic S, G. A reduction in the hepatic venous pressure gradient (HVPG) prevents clinical outcomes in compensated clinically significant portal hypertension in patients with NASH cirrhosis](https://doi.org/10.1016/s0168-8278(17)30461-0)Ilan Y, Harrison S, Traber P, Chalasani N, Garcia-Tsao G. LBP-516 13C-Methacetin Breath Test accurately assesses clinically significant portal hypertension in patients with NASH cirrhosis Of Tandon P, Biggins S, Kamath P, Lai J, Fallon M, Subramanian R, Maliakkal B, Thuluvath P, Vargas H, Thacker L, Reddy R, Disease N. FRI-025 Albumin use and acute kidney injury in a large real-world analysis of diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases](http://www.ncbi.nlm.nih.gov/pubmed/27786365)GarciaTsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases discharge in patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/27775842)Tandon P, Reddy KR, O'Leary JG, GarciaTsao N. A Karnofsky performance status-based score predicts death after hospital discharge in Francoz C, Garcia-Tsao G, Gin\u00e8s P, Ison MG, Kramer DJ, Mehta RL, Moreau R, JC, critically cirrhosis: A multidisciplinary in patients with cirrhosis and ascites: type [PMID: 27207973](https://pubmed.ncbi.nlm.nih.gov/27207973), [DOI: 10.1136/gutjnl-2016-312129](https://doi.org/10.1136/gutjnl-2016-312129). [AISF position paper on liver transplantation and pregnancy Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)](http://www.ncbi.nlm.nih.gov/pubmed/27267817)Alisi A, Balsano C, Bernabucci V, Berzigotti E, Coco B, Colle I, Critelli R, De Martin E, Del Buono M, Fabregat I, Faillaci F, Fattovich G, Floreani G, Smedile A, Burra P, Rodr\u00edguez-Castro K, Guarino M, Morisco F, Villa E, Mazzella G. AISF position paper on liver transplantation and pregnancy Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) Digestive And Spontaneous Bacterial Peritonitis (SBP): Incidence, Risk Factors, Clinical Impact, and Antibiotic Choices](https://doi.org/10.1016/s0016-5085(16)33749-0)To U, Delisle A, Garcia-Tsao G. Su1493 Non-Response to Empirical Treatment for Spontaneous Bacterial Peritonitis (SBP): Incidence, Risk Factors, Clinical Impact, and 150: Patients With Ascites Is Associated With a Lower MELD, Less Inflammation and an Improved Survival](https://doi.org/10.1016/s0016-5085(16)33659-9)Bhutta A, Garcia-Tsao G, Reddy K, Tandon P, Wong J, Acharya C, Banerjee D, Abraldes J, Plener I, Jones T, Shaw J, Deng Y, Ciarleglio M, Bajaj J. Sa1645 Beta-Blocker (BB) Use in Hospitalized Cirrhotic Patients With Ascites Is Associated With a Lower MELD, Less Inflammation and an Improved Survival Gastroenterology 2016, 150: ACLF and Varies Significantly Across America: NACSELD Experience](https://doi.org/10.1016/s0016-5085(16)33769-6)Bajaj J, Reddy K, Tandon S, Fallon M, Maliakkal B, Thuluvath P, Subramanian R, H, Lai J, Thacker L, O'Leary J. Su1513 In-Hospital Mortality Related to Hepatic Encephalopathy Is Independent of ACLF and Varies Significantly 150: s1117. [DOI: Mortality After Discharge From Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score](https://doi.org/10.1016/s0016-5085(16)33906-3)Tandon P, Reddy K, O'Leary J, Garcia-Tsao P, Thacker L, Bajaj J. Tu1649 Predicting Mortality After Discharge From Hospital in Cirrhosis: A Prospective Assessment of the unacceptably high in a large North American cohort of patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/26690389)Bajaj JS, Reddy KR, Tandon Biggins SW, RM, LR, JG, Disease N. The 3month readmission rate remains unacceptably high in a large North American cohort of patients and Its Complications 2016, 447-458. [DOI: 10.1002/9781118512104.ch55](https://doi.org/10.1002/9781118512104.ch55). [THU-001 Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with a Lower Meld, less Inflammation and an Improved Survival](https://doi.org/10.1016/s0168-8278(16)00253-1)Bhutta A, Garcia-Tsao G, Reddy R, Tandon P, Wong J, Acharya C, Banerjee D, Abraldes J, Plener I, Jones T, Shaw J, Deng Y, Ciarleglio M, Bajaj J. THU-001 Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with a Lower Meld, less Inflammation and an Improved Survival Journal Of Hepatology 2016, 64: s245. [DOI: 10.1016/s0168-8278(16)00253-1](https://doi.org/10.1016/s0168-8278(16)00253-1). [THU-373 Predicting Mortality after Discharge from Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score](https://doi.org/10.1016/s0168-8278(16)00340-8)Tandon P, Reddy R, O'Leary J, Garcia-Tsao P, Thacker L, Bajaj J. THU-373 Predicting Mortality after Discharge from Hospital in Cirrhosis: A Prospective Assessment of the Karnofsky Score Journal Of Hepatology 2016, 64: s282. [DOI: of Current Therapies at Variceal Rebleeding on Other Complications of Cirrhosis](https://doi.org/10.1007/978-3-319-23018-4_33)Ripoll C, Augustin S, Reiberger T, Moreau R, Salerno F, Albillos A, Abraldes J, Garcia-Tsao G. Effect of Current Therapies Aimed at Preventing Variceal Rebleeding on Other Complications of Cirrhosis Augustin Salerno F, Moreau R, Reiberger T, Garcia-Tsao G. Impact of Treatment of Non-bleeding Complications of Cirrhosis on the Risk of Variceal Bleeding 341-353. Albillos A, Moreau R, Salerno F, Abraldes J. Introduction and Survey Results 2016, 303-309. [DOI: 10.1007/978-3-319-23018-4_30](https://doi.org/10.1007/978-3-319-23018-4_30). Abraldes T, Ripoll C, F, Garcia-Tsao G. Consensus Statements: Preventing Recurrent Hemorrhage S, Salerno F, Abraldes J, Garcia-Tsao G. Secondary Prophylaxis in Special Patient Populations 317-332. 10.1007/978-3-319-23018-4_32](https://doi.org/10.1007/978-3-319-23018-4_32). A, Abraldes Augustin S, R, G. Prevention of 2016, 311-316. [THU-347 Progressive Alterations in Systemic and Cardiopulmonary Hemodynamics Occur in Patients with Cirrhosis and Predict Death in Decompensated Cirrhosis](https://doi.org/10.1016/s0168-8278(16)00314-7)Turco L, Garcia-Tsao G, Magnani I, Bianchini M, Costetti M, Rossi R, Villa E, Schepis F. THU-347 Progressive Alterations in Systemic and Cardiopulmonary Hemodynamics Occur in Patients with Cirrhosis and Predict Death in Cirrhosis Reiberger T, Moreau R, Albillos A, Garcia-Tsao G. Issues in Trial Design and Areas Needing Further Research 2016, 355-363. [DOI: 10.1007/978-3-319-23018-4_35](https://doi.org/10.1007/978-3-319-23018-4_35). - GarciaTsao [DOI: 10.1002/9781118512074.ch106](https://doi.org/10.1002/9781118512074.ch106). [Corrigendum to \"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites\" [J Hepatol 2015;62:968-974]](https://doi.org/10.1016/j.jhep.2015.04.001)Angeli P, Gin\u00e8s P, Wong T, Gerbes A, Moreau R, Jalan R, Sarin S, Piano S, Moore K, Lee S, Durand F, Salerno F, Caraceni P, Kim W, Arroyo V, Garcia-Tsao G. Corrigendum to \"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites\" [J Hepatol 10.1016/j.jhep.2015.04.001](https://doi.org/10.1016/j.jhep.2015.04.001). [High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of endstage liver disease](http://www.ncbi.nlm.nih.gov/pubmed/25845966)Reddy KR, O'Leary JG, Kamath RM, Thacker LR, Bajaj JS, Disease F. High risk of delisting or death in liver transplant candidates following infections: Results from the North American consortium for the study of endstage liver disease Liver Transplantation 2015, 21: 881-888. [PMID: : The a large multi-center cohort of cirrhotic patients](https://doi.org/10.1016/s0168-8278(15)30340-8)Bajaj J, Reddy K, Garcia-Tsao B, Kamath L, of O. P0120 : The 3-month readmission rate remains unacceptably high in a large multi-center cohort of cirrhotic patients Journal Of Hepatology 2015, P, Vargas H, Thacker L, Bajaj J. Mo1892 Acute Kidney Injury in Cirrhosis: Multi-Center Cohort of Cirrhotic Patients](https://doi.org/10.1016/s0016-5085(15)33360-6)Bajaj J, Reddy K, Garcia-Tsao B, Kamath J. 575 The 3-Month Readmission Rate Remains Unacceptably High in a Large cohort](https://doi.org/10.1016/s0168-8278(15)30339-1)O'Leary J, Reddy K, Garcia-Tsao G, Biggins J, Of The NACSELD Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) score in an (I-ACLF) Definition for 30-Day Mortality Prediction in Infected and Uninfected Hospitalized Cirrhotic Patients](https://doi.org/10.1016/s0016-5085(15)33376-x)O'Leary J, Reddy K, Garcia-Tsao G, Biggins Infection-Related Acute-on-Chronic Liver Failure (I-ACLF) Definition for 30-Day Mortality Prediction in Infected and Uninfected Hospitalized Cirrhotic Patients Gastroenterology 2015, 148: use decreases and death in veterans with hepatitis C-related compensated cirrhosis](https://doi.org/10.1016/s0168-8278(15)30086-6)Mohanty A, Tate J, Garcia-Tsao G. O072 : Statin use significantly decreases decompensation and death in veterans with hepatitis C-related compensated cirrhosis Journal Of Hepatology 2015, B, Tandon P, Vargas H, Thacker L, Bajaj J, Disease N. P0199 : Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient 10.1016/s0168-8278(15)30418-9](https://doi.org/10.1016/s0168-8278(15)30418-9). [231/356 Statin Use and the Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis](https://doi.org/10.1016/s0016-5085(15)33322-9)Mohanty A, Tate J, Garcia-Tsao G. 231/356 Statin Use and the Risk of Decompensation and Death in Veterans With Hepatitis C-Related H, Ansari N, Coca SG, GarciaTsao G, Parikh CR, Consortium F. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute R, Subramanian RM, LR, Kamath PS, Disease T. Survival in infectionrelated acuteonchronic liver failure is defined by 13: 171-179. [DOI: Intra-and Inter-Observer Variability Munoz C, Augustin S, Loo N, Deng Y, Ciarleglio M, Garcia-Tsao G. Sa1004 Measurement of Liver and Associated With Sustained Virological Response in Patients With Hepatitis C Treated With Pegylated Interferon and Ribavirin, Independent of Host Metabolic Factors](https://doi.org/10.1016/s0016-5085(14)63541-1)Sanchez M, Augustin S, Balakrishnan M, Re V, Tate J, Garcia-Tsao G. Su1050 Statin Use Is Associated With Sustained Virological Response in Patients With Hepatitis C Treated With Pegylated Interferon and Ribavirin, Independent of 10.1016/s0016-5085(14)63541-1](https://doi.org/10.1016/s0016-5085(14)63541-1). Cirrhotic Women: The Nacseld Experience](https://doi.org/10.1016/s0016-5085(14)63596-4)O'Leary J, Wong S, Fallon B, R, Thacker L, Bajaj J. Mo1027 Differences in Creatinine Between Genders Could Disadvantage INTRA- AND INTER-OBSERVER VARIABILITY Souza F, Munoz C, Augustin S, Loo N, Deng Y, Ciarleglio M, Garcia-Tsao G. P1013 MEASUREMENT OF LIVER AND SPLEEN BY ELASTOGRAPHY: INTRA- AND INTER-OBSERVER DESPITE PROPHYLACTIC MEASURES: PROSPECTIVE MULTI-CENTER STUDY FROM NACSELD](https://doi.org/10.1016/s0168-8278(14)60664-4)Biggins O'Leary Reddy K, Wong Kamath M, Garcia-Tsao G, Subramanian R, Thuluvath P, Maliakkal B, Koch D, Malik R, Thacker L, Bajaj J. P502 SPONTANEOUS BACTERIAL PERITONITIS AND BACTEREMIA MORTALITY IN CIRRHOSIS DESPITE PROPHYLACTIC MEASURES: A PROSPECTIVE 10.1016/s0168-8278(14)60664-4](https://doi.org/10.1016/s0168-8278(14)60664-4). WOMEN: THE NACSELD EXPERIENCE](https://doi.org/10.1016/s0168-8278(14)61104-1)Bajaj J, O'Leary S, Patton H, Maliakkal B, Thuluvath G, D, Thacker L, Kamath P. P943 DIFFERENCES IN CREATININE BETWEEN GENDERS COULD DISADVANTAGE INFECTED CIRRHOTIC WOMEN: THE Journal Of Groszmann Stalling C, Grace ND, Burroughs AK, Patch D, Matloff DS, Clopton P, Chojkier M. Novel inflammatory biomarkers of portal pressure new onset ascites: A diagnostic accuracy study](http://www.ncbi.nlm.nih.gov/pubmed/23907731)Farias AQ, Silvestre peptide the initial workup of patients with new onset ascites: A diagnostic [DOI: 10.1002/hep.26643](https://doi.org/10.1002/hep.26643). [New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection](http://www.ncbi.nlm.nih.gov/pubmed/23999172)Wong F, O'Leary B, Thacker LR, Bajaj JS, Disease N. New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and ascites analyses in the diagnosis of ascites related to heart failure](https://doi.org/10.1093/eurheartj/eht309.p4241)Farias A, Silvestre O, Bacal peptide is more accurate than ascites analyses in the diagnosis of ascites related to heart failure European Heart Journal 2013, 34: p4241-p4241. [DOI: 10.1093/eurheartj/eht309.p4241](https://doi.org/10.1093/eurheartj/eht309.p4241). - Fortune BE, GarciaTsao G. Hypervolemic hyponatremia: Clinical significance and management Clinical [PMID: 30992838](https://pubmed.ncbi.nlm.nih.gov/30992838), [PMCID: PMC6448632](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448632), [DOI: 10.1002/cld.179](https://doi.org/10.1002/cld.179). [Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary GarciaTsao G. Bevacizumab: Finding its niche in the treatment of heart failure secondary to liver vascular malformations Image Analysis Can Predict Hpvg and Help in Sub-Classification of Cirrhosis](https://doi.org/10.1016/s0016-5085(13)63404-6)Alduaij A, Jain D, A, Demetris A, G, Scott R. Tu2048 Histological Features Using Quantitative Morphometric Digital Image Analysis Can Predict Hpvg and Help Acute Kidney Injury in Patients With Cirrhosis: Perils and Promise Clinical Lim JK, Ansari N, Coca SG, Parikh CR, Consortium F. Association of AKI With mortality and complications in hospitalized patients with the Spleen Gets Tough, the Among Patients With Cirrhosis at a US Liver Center](http://www.ncbi.nlm.nih.gov/pubmed/22902776)Tandon P, DeLisle A, Topal JE, Garcia-Tsao G. High Prevalence of Antibiotic-Resistant Bacterial Infections Among Patients With Cirrhosis at a US Liver Center Clinical Not Superior to Albumin in Preventing Recurrence of Ascites After Large-Volume Paracentesis](http://www.ncbi.nlm.nih.gov/pubmed/22801062)Bari H, D, Garcia-Tsao G. The Combination of Octreotide and Midodrine Is Not Superior to Albumin in Preventing Recurrence of Ascites After Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class](https://doi.org/10.1016/s0016-5085(12)63744-5)Bari K, Augustin S, Eggers C, Hashem H, Desai M, Shea M, Wongcharatrawee S, Lim J, Garcia-Tsao G. Sa1091 Hepatitis C (HCV) Antiviral Therapy is Feasible in Patients With Active Substance use (SU) and Mental Illness (MI) and is More Likely to Occur in Those Who Receive Education Class Gastroenterology 2012, 142: s-967. [DOI: C, J, Richter J, Chan F. Functional Gastrointestinal Disease 2012, [The (EV), but not treatment with beta-blockers, is associated with a poorer survival in patients with cirrhosis and ascites](https://doi.org/10.1055/s-0031-1295840)Zipprich A, Garcia-Tsao G, Seufferlein T, Dollinger M. The presence of esophageal varices (EV), but not treatment with beta-blockers, is associated with a poorer survival in patients with cirrhosis and ascites Zeitschrift F\u00fcr Gastroenterologie 999-1007. [DOI: 10.1016/b978-1-4377-1604-7.00156-1](https://doi.org/10.1016/b978-1-4377-1604-7.00156-1). - Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, GarciaTsao G, Kamath PS. Intensive care of transplantation on the survival of patients treated for hepatorenal syndrome type 1*](http://www.ncbi.nlm.nih.gov/pubmed/21837734)Boyer TD, Sanyal AJ, GarciaTsao V, Sigal S, Bexon AS, Teuber P, Group T. Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1* Burroughs AK, Morillas R, A, GarciaPagan J, Patch D, Matloff DS, Groszmann RJ, Group T. Obesity is an independent risk factor for clinical decompensation in patients 165-181. Garcia-Tsao G. Albilllos A, G. Classification of Cirrhosis: The Clinical Use of HVPG Measurements Disease Markers 2011, 31: 121-128. [DOI: 10.1155/2011/706032](https://doi.org/10.1155/2011/706032). [Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis](http://www.ncbi.nlm.nih.gov/pubmed/21145427)Tandon P, Garcia-Tsao G. Renal Dysfunction Is the Most Important Independent Predictor of Mortality in Cirrhotic Patients With Spontaneous Bacterial Peritonitis Lim J, Tandon P, Garcia-Tsao G. Antibiotic Prophylaxis and Management 2010, 395-410. [DOI: 10.1007/978-1-60761-866-9_20](https://doi.org/10.1007/978-1-60761-866-9_20). [Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/20492521)Salerno F, Guevara M, Bernardi M, Moreau R, Wong F, Angeli P, GarciaTsao G, Lee SS. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis Liver International Beta-Blockers Protects Against Worsening of Thrombocytopenia in Cirrhosis](https://doi.org/10.1016/s0016-5085(10)63764-x)Qamar A, Grace N, Groszmann R, Garcia-Tsao G, Bosch J, Burroughs A, Iskandar H, Maurer R, Planas R, Escorsell A, Garcia-Pagan J, Patch D, Matloff D, Makuch R, From P. S1918 A Hemodynamic Response to Treatment With Non-Selective Beta-Blockers Protects s-817. [DOI: 10.1016/s0016-5085(10)63764-x](https://doi.org/10.1016/s0016-5085(10)63764-x). No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/20144739)Tandon P, Inayat I, Tal M, Spector M, Shea M, Groszmann RJ, Garcia-Tsao G. Sildenafil Has No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated Cirrhosis to Qi et al. The American Journal Of Gastroenterology 2010, 105: 472. [DOI: 10.1038/ajg.2009.628](https://doi.org/10.1038/ajg.2009.628). [Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/20077563)GarciaTsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological hemorrhage: And the winner is...](http://www.ncbi.nlm.nih.gov/pubmed/19714716)Bosch J, GarciaTsao G. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program](https://doi.org/10.1038/ajg.2009.360)Garcia-Tsao G, Lim J. Erratum: Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program The American Journal Of Gastroenterology 2009, 104: ajg2009360. [DOI: 10.1038/ajg.2009.360](https://doi.org/10.1038/ajg.2009.360). With Acute Decompensation in Patients With Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/19394441)Khalid SK, Lane J, Navarro V, Garcia-Tsao G. Use of Over-the-Counter Analgesics Is Not Associated With Acute Decompensation in Patients A, 233 QUANTITATIVE HISTOLOGICAL ASSESSMENT CIRRHOSIS: s94. [DOI: 10.1016/s0168-8278(09)60235-x](https://doi.org/10.1016/s0168-8278(09)60235-x). [Incidence, Prevalence, and Clinical Significance of in Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/19281860)Qamar AA, Grace ND, Groszmann Planas R, Escorsell A, Garcia-Pagan J, Patch D, Matloff DS, Makuch R, Rendon G, Group P. Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis with Ascites and its Complications 2009, 103-113. Hepatic hereditary Combes B, Mills AS, Markin RS, Rubin R, Wheeler D, Contos M, West AB, Saldana S, Getachew Y, Butsch R, Luketic V, Peters M, Di Bisceglie A, Bass N, Lake J, Boyer T, Martinez E, Boyer J, GarciaTsao G, Barnes D, Rosenberg WM. Prediction of clinical outcomes in primary biliary cirrhosis Ascites and Its Complications 2008, 442-466. [DOI: 10.1002/9781444300758.ch23](https://doi.org/10.1002/9781444300758.ch23). [Portal hypertension and variceal bleeding\u2014Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver singletopic conference](http://www.ncbi.nlm.nih.gov/pubmed/18435460)GarciaTsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding\u2014Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver singletopic Syndrome](http://www.ncbi.nlm.nih.gov/pubmed/18471513)Sanyal Boyer T, Garcia-Tsao Regenstein B, Blei A, V, P, T. A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of Terlipressin Infections, Sepsis, and Multiorgan Failure in Cirrhosis Seminars In Liver INDICATORS STAGES OF LIVER CIRRHOSIS: VALIDATION OF A Rogowski S, Fleig W. 317 PROGNOSTIC INDICATORS OF SURVIVAL IN COMPENSATED AND DECOMPENSATED STAGES OF LIVER CIRRHOSIS: VALIDATION OF A count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/18161700)Qamar AA, Grace Escorsell A, GarciaPagan J, Patch D, Matloff DS, Makuch R, Group P. Platelet count is not a predictor of the presence or development of gastroesophageal project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage](http://www.ncbi.nlm.nih.gov/pubmed/17935182)Longacre AV, Imaeda A, GarciaTsao G, Fraenkel L. A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis and Hispanic patients with primary biliary cirrhosis in the United States](http://www.ncbi.nlm.nih.gov/pubmed/17654740)Peters MG, TD, Lake JR, Bonacini M, Combes B, Group P. Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the Grace ND, Carey W, Diseases T. Prevention and management of gastroesophageal Patients With Compensated Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/17681169)Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan J, Makuch R, Patch D, Matloff DS, Bosch J, Group P. Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in J. Model for endstage liver disease (MELD) exception for hereditary hemorrhagic Sabb\u00e0 C, Miller F, Saurin JC, Pelage JP, Lesca G, Marion MJ, Perna A, Faughnan ME. Liver involvement in hereditary hemorrhagic [DOI: 10.1053/j.gastro.2006.06.054](https://doi.org/10.1053/j.gastro.2006.06.054). - Garcia-Tsao G. Portal hypertension Current Opinion In Internal Medicine 2006, 5: 399-407. [DOI: 10.1097/01.mog.0000218962.93806.9a](https://doi.org/10.1097/01.mog.0000218962.93806.9a). - GarciaTsao G, D'Amico G, Abraldes J, Schepis F, Merli M, Kim W, Christensen E. Session 2: Predictive Models in Portal Hypertension 2006, 47-102. [DOI: 10.1002/9780470988831.ch4](https://doi.org/10.1002/9780470988831.ch4). - [DOI: 10.1016/b978-1-4160-3258-8.50024-3](https://doi.org/10.1016/b978-1-4160-3258-8.50024-3). [Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders](http://www.ncbi.nlm.nih.gov/pubmed/16611189)Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Sernyak M, Wongcharatrawee S, GarciaTsao G. Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders Journal Of Viral Hepatitis 2005, 13: 235-241. [PMID: RL, JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, Barnes DS, Bonacini M, Lindsay KL, Mills AS, Markin RS, Rubin R, AB, AF. Methotrexate (MTX) G. Transjugular 2005, 251-259. [DOI: 10.1002/9780470987476.ch20](https://doi.org/10.1002/9780470987476.ch20). M, Balk R, Christman B, Moreau R, Garcia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis 1963; in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome [Ann Intern Med 1964; 60: 568-580]](https://doi.org/10.1016/s0168-8278(04)00392-7)GARCIATSAO G. Spontaneous bacterial peritonitis: a historical perspectiveKerr DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis 1963; in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome [Ann Intern Med 1964; G. Treatment of acute variceal bleeding: general management and on the consensus conference of the international Ascites club](http://www.ncbi.nlm.nih.gov/pubmed/12830009)Moore K, Wong F, Gines P, Bernardi M, Ochs Salerno F, Angeli M, Moreau R, GarciaTsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: Report on the consensus conference of the Intestinal Flora in Experimental Prehepatic Portal Hypertension](http://www.ncbi.nlm.nih.gov/pubmed/12822876)Wiest R, Chen F, Cadelina G, Groszmann R, Garcia-Tsao G. Effect of Lactobacillus-Fermented Diets on Bacterial Translocation and Intestinal Flora in Experimental Prehepatic Portal Hypertension Digestive And 12822876](https://pubmed.ncbi.nlm.nih.gov/12822876), [DOI: 10.1023/a:1023729115659](https://doi.org/10.1023/a:1023729115659). - GarciaTsao G. Portal In Internal Medicine 2003, 2: 229-237. [DOI: 10.1097/00132980-200302030-00003](https://doi.org/10.1097/00132980-200302030-00003). [Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA)](https://doi.org/10.1016/s0016-5085(03)83945-8)Chainuvati S, Khalid S, Kancir S, Shea M, Edwards J, Semyak M, Wongcharatrawee S, Garcia-Tsao G. Comparison of hepatitis C (HCV) treatment patterns in patients with and without mental illness (MI) and/or substance abuse (SA) the prevention of the complications of portal hypertension: final results and identification of a predictive factor](https://doi.org/10.1016/s0270-9139(03)80146-5)Groszmann R, Garcia-Tsao G, Makuch R, Bosch J, Escorsel A, Garcia-Pagan J, Grace N, Matloff D, Burroughs A, Patch D. 103 Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor Hepatology 2003, 38: 206. [DOI: 10.1016/s0270-9139(03)80146-5](https://doi.org/10.1016/s0270-9139(03)80146-5). [553 Histologic-hemodynamic correlations in hepatitis C and other chronic liver diseases \u2014 is there a histologically mild and severe cirrhosis?](https://doi.org/10.1016/s0270-9139(03)80595-5)Nagula S, Jain D, Groszmann R, Garcia-Tsao G. 553 Histologic-hemodynamic correlations in hepatitis C and other chronic liver diseases \u2014 is there a histologically mild and severe analgesics to therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?](http://www.ncbi.nlm.nih.gov/pubmed/11839726)Burroughs A, Groszmann R, Bosch J, Grace N, Garcia-Tsao G, Patch D, Garcia-Pagan J, Dagher L. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better Bosch J, GarciaTsao G, Richardson C, Matloff D, Rod\u00e9s J, Conn H. Propranolol for the prevention of first esophageal variceal CLINICAL MANAGEMENT OF ASCITES AND ITS COMPLICATIONS Clinics In Liver Disease 2001, 5: 833-850. [PMID: 11565143](https://pubmed.ncbi.nlm.nih.gov/11565143), [DOI: 10.1016/s1089-3261(05)70194-x](https://doi.org/10.1016/s1089-3261(05)70194-x). - Garcia-Tsao [PMID: hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis](http://www.ncbi.nlm.nih.gov/pubmed/11179247)Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal Henderson J, Laine L, Nevens F, Riggio O. Session 1 Definition of Key Events: Lets's Try Again 2001, 13-21. [DOI: 10.1002/9780470760154.ch2](https://doi.org/10.1002/9780470760154.ch2). Nevens F, Cestari R, Caletti G, Zoli M. Session 2 Diagnosis of Portal Hypertension: How and When 2001, 36-64. [DOI: 10.1002/9780470760154.ch4](https://doi.org/10.1002/9780470760154.ch4). P, Merli M, Rodes J, Stiegmann G. Session 8 Complications in the Medical Treatment of Portal Hypertension 2001, 180-203. [DOI: 10.1002/9780470760154.ch12](https://doi.org/10.1002/9780470760154.ch12). [Prokinetics reduce bacterial translocation in cirrhosis: Will sweeping the gut keep the fluid clean?](http://www.ncbi.nlm.nih.gov/pubmed/11208746)Garc\u00eda-Tsao G. Prokinetics reduce bacterial translocation in cirrhosis: Will sweeping the gut L, Henderson K, Jain D, Byrd B, Pollak J, White R. Liver Disease in Patients with Hereditary Hemorrhagic Telangiectasia New England Journal Of 11006369](https://pubmed.ncbi.nlm.nih.gov/11006369), [DOI: 10.1056/nejm200009283431305](https://doi.org/10.1056/nejm200009283431305). - [PMID: 17023887](https://pubmed.ncbi.nlm.nih.gov/17023887), [DOI: 10.1097/00001574-200005000-00012](https://doi.org/10.1097/00001574-200005000-00012). [Ultrasound the of clinically significant portal hypertension (CS-PHT) in compensated cirrhosis](https://doi.org/10.1016/s0016-5085(00)86014-x)Ayala J, Zalwin M, Taylor C, Bosch J, Groszmann R, Garcia-Tsao G. Ultrasound parameters in the prediction of clinically significant portal hypertension (CS-PHT) in compensated cirrhosis L, Planas R, Bernard B, Inadomi J, Club T. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document R. Bacterial and Wheeler D, Rubin R, West A, Mills A, Eigenbrodt E, Maddrey W, Munoz S, GarciaTsao G, Bonner G, Boyer J, Luketic V, Shiffman M, Peters M, White H, Zetterman R, Carithers R. The effect of ursodeoxycholic acid therapy of portal hypertension: A caution](http://www.ncbi.nlm.nih.gov/pubmed/10464155)Garc\u00eda-Tsao G. Angiotensin II receptor antagonists in the pharmacological therapy of portal - Identifying new risk factors for spontaneous bacterial peritonitis: How important G, Bonner G, Boyer J, Luketic V, Shiffman M, Peters M, White H, Zetterman R, Risser R, Rossi S, Hofmann A. Biliary bile in pressure measurements](http://www.ncbi.nlm.nih.gov/pubmed/10094948)Steinlauf A, GarciaTsao G, T, Groszmann R. Lowdose midazolam sedation: An option for patients A, Pagliaro L, Makuch R, Bosch J, Stiegmann G, Henderson J, de Franchis R, Wagner J, Conn H, Rodes J. Portal hypertension and variceal bleeding: An of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis](http://www.ncbi.nlm.nih.gov/pubmed/9657091)GarciaTsao G, Angulo P, Garcia J, Groszmann R, Cadelina G. The diagnostic and predictive value of ascites nitric oxide levels in patients with 1998, 14: 256-264. [DOI: 10.1097/00001574-199805000-00012](https://doi.org/10.1097/00001574-199805000-00012). - Garc\u00eda-Tsao G. Further against Garcia-Tsao G, Cartun R, Emanuel J, West A. Viral RNA in duodenal bile of cirrhotic patients with chronic hepatitis C. Archives Of Pathology & Laboratory Medicine 1997, 121: 847-52. [PMID: 9278613](https://pubmed.ncbi.nlm.nih.gov/9278613). [The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than in those with varices](http://www.ncbi.nlm.nih.gov/pubmed/9178694)Escorsell A, Ferayorni L, Bosch J, Garcia-Pagan J, Garcia-Tsao G, Grace N, Rodes J, Groszmann R. The portal pressure response to beta-blockade is greater in cirrhotic patients without varices than favor portal pressure reduction in the prevention of variceal hemorrhage](http://www.ncbi.nlm.nih.gov/pubmed/9136864)Garc\u00eda-Tsao G. Further evidence in favor of pharmacological portal pressure reduction in the prevention 1997, 13: 263-270. [DOI: 10.1097/00001574-199705000-00013](https://doi.org/10.1097/00001574-199705000-00013). Opinion Gastro 13:263-270, 1997. [Doppler ultrasound in the cirrhotic patients: The prevalence of intrahepatic arteriovenous shunting, and implications for diagnosis of hepatocellular carcinoma](http://www.ncbi.nlm.nih.gov/pubmed/9372563)Taylor C, Garcia-Tsao G, Henson B, Case C, Taylor K. Doppler ultrasound in the evaluation of cirrhotic patients: The prevalence of intrahepatic arteriovenous shunting, and implications for diagnosis of hepatocellular carcinoma Ultrasound In Medicine & Biology 1997, 23: 9372563](https://pubmed.ncbi.nlm.nih.gov/9372563), ofloxacin: Inpatient or outpatient therapy?](http://www.ncbi.nlm.nih.gov/pubmed/8831614)Garc\u00eda-Tsao G. Treatment of spontaneous bacterial peritonitis with oral B, Carithers R, Maddrey W, Lin D, McDonald M, Wheeler D, Eigenbrodt E, Mu\u00f1oz S, Rubin R, Garcia-Tsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A placebo-controlled trial cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/7657280)Combes B, Carithers R, Maddrey W, Lin D, McDonald M, Wheeler D, Eigenbrodt E, Mu\u00f1oz S, Rubin R, GarciaTsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A randomized, cirrhosis](https://doi.org/10.1016/0270-9139(95)90294-5)Combes B, Carithers R, Maddrey W, Lin D, Mcdonald M, Wheeler D, Eigenbrodt E, Mu\u00f1oz S, Rubin R, Garcia-tsao G, Bonner G, West A, Boyer J, Luketic V, Shiffman M, Mills A, Peters M, White H, Zetterman R, Rossi S, Hofmann A, Markin R. A randomized, Cartun R, West A. Bacterial translocation to mesenteric lymph nodes is increased in 10.1016/0016-5085(95)90147-7](https://doi.org/10.1016/0016-5085(95)90147-7). S, Emanuel J, Howe C, West A, Garcia-Tsao G. Detection of hepatitis C virus RNA by RT-PCR in the bile of patients with hepatitis C Antonica G, Ferraioli G, Jensen J, Lerner E, Antonica G, Ferraioli G, Jensen J, Lerner E, Portal Vein Thrombosis, and Cirrhosis](http://www.ncbi.nlm.nih.gov/pubmed/7806833)Orozco T, Garcia-Tsao G, Mercado M, Prado E, Nava R. A Comparative Clinical Study of Idiopathic Portal Hypertension, Extrahepatic Portal Vein Thrombosis, and GarciaTsao Bacterial translocation in acute and chronic Garcia-Tsao G. Decreasing Liver Biopsy Annals Of Internal Medicine 1993, 119: 436. [DOI: 10.7326/0003-4819-119-5-199309010-00020](https://doi.org/10.7326/0003-4819-119-5-199309010-00020). - GarciaTsao G, Albillos A, Barden G, West A. Bacterial translocation in acute and chronic hypertension [PMID: 8514258](https://pubmed.ncbi.nlm.nih.gov/8514258), Outpatient liver biopsy: how safe is it? Annals Of Internal Capell\u00e1n^S J, Garcia-Tsao G. Elective treatment of bleeding varices with the Sugiura operation over 10 years The American Journal Of cause of acute anemia in a patient with the acquired immunodeficiency syndrome](http://www.ncbi.nlm.nih.gov/pubmed/1537498)Garcia-Tsao G, Panzini L, Yoselevitz M, West A. Bacillary peliosis hepatis as a cause of acute anemia in a patient with the acquired immunodeficiency syndrome R, [The Sugiura hypertension secondary to extrahepatic portal vein thrombosis.](http://www.ncbi.nlm.nih.gov/pubmed/1866670)Orozco H, Takahashi T, Mercado M, Garcia-Tsao G, Hernandez-Ortiz J. The Sugiura procedure for patients with hemorrhagic portal hypertension secondary to extrahepatic portal vein thrombosis. Journal Of The American College Of Surgeons 1991, 173: 45-8. [PMID: 1866670](https://pubmed.ncbi.nlm.nih.gov/1866670). [Propranolol in the esophagogastric varices: A multicenter, randomized Groszmann R, Rod\u00e9s J, Wright S, Matloff D, GarciaTsao G, Fisher R, Navasa M, Drewniak S, Atterbury C, Bordas J, Lerner E, Bramante C. Propranolol in the prevention of the first hemorrhage from esophagogastric with tense ascites treated with total paracentesis: results of a randomized study Planas R, Gines P, Arroyo V, Llach J, J, V, JM, Dextran-70 plasma-expanders in cirrhotic patients with tense ascites treated with total paracentesis: results of a randomized study Planas R, Gines P, Arroyo V, Llach J, F, Hernandez-Cendejas A. Partial hepatectomy for Caroli's syndrome. Report of two with prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage](http://www.ncbi.nlm.nih.gov/pubmed/2210246)Groszmann R, Bosch J, Grace N, Conn H, Garcia-Tsao G, Navasa M, Alberts J, Rodes J, Fischer R, Bermann M, Rofe S, Patrick M, Lerner E. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of Gonzalez-Lopez-Lira A, Hernandez-Ortiz J. Postoperative portal vein obstruction in patients with idiopathic portal hypertension. Journal Of Clinical Guevara L, Ort\u00edz J, A, Tielve M. Role of the distal splenorenal shunt in management of variceal bleeding in Latin America The American Journal Of Surgery 1990, 160: 86-89. L, Hernandez-Ortiz J, Tielve M. Selective portal-systemic shunts for bleeding Garc\u00eda-Tsao G, Hern\u00e1ndez-Ortiz J. Surgical treatment of hemorrhage of esophageal varices secondary to thrombosis of the portal microbiologic study of liver biopsy in the diagnosis of fever of unknown origin.](http://www.ncbi.nlm.nih.gov/pubmed/2291060)P\u00e1ez-Rodr\u00edguez O, Garc\u00eda-Tsao G, Sifuentes J. Usefulness of the histologic and microbiologic study of liver biopsy in the diagnosis of fever of unknown origin. Revista Gastroenterolog\u00eda placebocontrolled trial](http://www.ncbi.nlm.nih.gov/pubmed/2511136)Bosch J, Garc\u00edaTsao G, M, A, Rod\u00e9s J. Association of transdermal nitroglycerin to vasopressin infusion in the treatment of Takahashi T. Idiopathic portal hypertension and protein C deficiency to editor 1989, Garcia-Tsao G. Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis. Journal Of Clinical R, Gent M, Rojkind M. fibropolycystic disease Mexico. trial](http://www.ncbi.nlm.nih.gov/pubmed/3056820)Grace N, Conn H, Resnick R, Groszmann R, Atterbury C, Wright S, Gusberg R, Vollman R, GarciaTsao G, Fisher R, O'Hara E, McDermott W, Maselli J, Widrich W, Matloff D, Horst D, Banks portalsystemic after R, Anaya R, RuizArguelles G, HernandezOrtiz J, Casillas M, Guevara L. Deficiency of protein C in patients with portal vein thrombosis Tamayo R, Gent M, Rojkind M. Colchicine in the Treatment of Cirrhosis of the Liver New England Journal Of Medicine 1988, 318: 1709-1713. [PMID: 3287167](https://pubmed.ncbi.nlm.nih.gov/3287167), [DOI: 10.1056/nejm198806303182602](https://doi.org/10.1056/nejm198806303182602). - M\u00e9xico S, liver and in patients with diffuse liver disease: importance of fat.](http://www.ncbi.nlm.nih.gov/pubmed/3520657)Taylor K, Riely C, Hammers L, Flax S, Weltin G, Garcia-Tsao G, Conn H, Kuc R, Barwick K. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. R, Conn H, Bermann M, Patrick M, Morse S, Alberts J. Shortterm effects of propranolol Garcia-Tsao E. The diagnosis of bacterial peritonitis Gastroenterology 1985, 89: 694. [DOI: 10.1016/0016-5085(85)90474-3](https://doi.org/10.1016/0016-5085(85)90474-3). - GarciaTsao R, Fisher R, Conn H, Atterbury C, Glickman M. Portal pressure, presence of gastroesophageal 10.1002/hep.1840050313](https://doi.org/10.1002/hep.1840050313). - GarciaTsao G, Conn H, Lerner E. The diagnosis of bacterial peritonitis: Comparison of pH, lactate concentration and 5: 91-96. [PMID: [DOI: 10.1002/hep.1840050119](https://doi.org/10.1002/hep.1840050119). - Guevara L, Garcia Tsao G, Uscanga L. A study with quinfamide in the treatment of chronic amebiasis in adults. Clinical Therapeutics 1983, 6: F, Vargas Laviada E, Mac\u00edas T, Ovalle F, Quibrera R, Rivera-Damm R, Vargas L, Valverde C. Study Group for Thyroid Cancer in Mexico (CATIMEX). Collaborative study of 194 F, Garc\u00eda Tsao G, Rojkind M, Kershenobich D. Early detection of alcoholism in a hospital population Relationship between blood lactic acid and Tsao G, V\u00e1zquez V, de la Rosa C, Guevara L. Collagen synthesis (C.S.) in acute bacterial intoxication after jejunal bypass (J.B.) Street, 1ANew Haven, CT 06510 - VA Connecticut Healthcare SystemVA Connecticut Healthcare950 Campbell Avenue, Wing West Haven CampusWest Haven, CT 06516 - Yale Digestive Street, 1ANew Haven, CT 06510 - VA Connecticut Healthcare SystemVA Connecticut Healthcare950 Campbell "}